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Children with autism spectrum disorder (ASD), a neurodevelopmental disability, 
continue to be affected by the disorder in adulthood. Research shows that many adults 
with ASD have poor outcomes in adulthood, regardless of intellectual ability or severity 
of symptom impairment, when compared to typically developing adults or adults with 
other disabilities. The burden of psychiatric comorbidities may be one of these 
contributing factors. 
 Several studies have been conducted to evaluate the prevalence of psychiatric 
comorbidity in individuals with ASD. and anxiety disorders are among the most common 
co-occurring psychiatric diagnoses in adults with ASD. Anxiety disorders are found to 
impact life outcomes in typically developing adults and it is possible they are also 
limiting individuals with ASD. Co-occurring anxiety has been widely studied in children 
and adolescents with ASD, but there is limited research on the prevalence and types of 
anxiety in adults with ASD. The aim of this study is to describe co-occurring anxiety 
disorders in a large sample of adults with ASD identified through medical billing codes 
from electronic healthcare records and in-person assessments of psychiatric conditions. 
The data on several participants who overlap will be compared to evaluate the validity of 
using medical billing codes to evaluate health status of participants with ASD. Lastly, 
associations between co-occurring anxiety and factors of adaptive functioning will be 
drawn for the potential that co-occurring anxiety may impact one’s ability to gain full 
	 iv	
independence. Ideally this study will help close the knowledge gap and provide important 
information for improving the identification and treatment of co-occurring anxiety in 
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 Children with autism spectrum disorder (ASD), a neurodevelopmental disability, 
display deficits in social communication and interaction, repetitive behaviors, restricted 
interests, and frequently have accompanied intellectual disability, language impairment, 
or comorbid medical or psychiatric conditions (American Psychiatric Association, 2013). 
This disorder occurs within a spectrum of impairment with some individuals showing 
severe disability and others showing minimal symptoms (Baker, 2013). Typically 
diagnosed during childhood, ASD continues to affect individuals well into adulthood. 
Research shows that many adults with ASD have poor outcomes in adulthood, regardless 
of intellectual ability or severity of symptom impairment, when compared to typically 
developing adults or adults with other disabilities (Barneveld, Swaab, Fagel, van 
Engeland, & de Sonneville, 2014; Billstedt, Gillberg, & Gillberg, 2005; Eaves & Ho, 
2008; Farley et al., 2009). The question still exists as to why these individuals are unable 
to live independently, maintain employment, and develop typical social relationships. 
Although symptoms of ASD, like rigidity or social communication deficits, can limit 
affected individuals, it is hypothesized that additional factors are contributing to 
difficulties in adulthood (Taylor & Mailick, 2014). The burden of psychiatric 
comorbidities may be one of these contributing factors (Buck et al., 2014). 
 Several studies have been conducted to evaluate the prevalence of psychiatric 
comorbidity in individuals with ASD (Buck et al., 2014; Cervantes & Matson, 2015; 
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Croen et al., 2015; Hallerback, & Gillberg, 2011; Hofvander et al., 2009; Joshi et al., 
2013; Kanne, Christ, & Reiersen, 2009; Lugnegard,). Anxiety, depression, and attention 
deficit hyperactivity disorder are among the common comorbid disorders diagnosed in 
individuals with ASD (Buck et al., 2014; Cervantes & Matson, 2015; Croen et al., 2015; 
Hofvander et al., 2009). Anxiety is among the most common co-occurring psychiatric 
diagnoses in adults with ASD (Buck et al., 2014) and has been found to impact life 
outcomes in typically developing adults (Barrera & Norton, 2009). Co-occurring anxiety 
has been widely studied in children and adolescents with ASD, but there is limited 
research on the prevalence and types of anxiety in adults with ASD. Without a clear 
understanding of the comorbid disorders seen in adults with ASD, it is challenging to 
develop and evaluate treatments to help these individuals obtain their maximum potential 
(Buck et al., 2014). The aim of this study is to describe co-occurring anxiety disorders in 
a large sample of adults with ASD identified through medical billing codes from 
electronic healthcare records and in-person assessments of psychiatric conditions. The 
data on several participants who overlap will be compared to evaluate the validity of 
using medical billing codes to evaluate health status of participants with ASD. Lastly, 
associations between co-occurring anxiety and factors of adaptive functioning will be 
examined to determine if co-occurring anxiety impacts one’s ability to gain full 
independence. Ideally, this study will help close the knowledge gap and provide 
important information for improving the identification and treatment of co-occurring 
anxiety in adults with ASD.  
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Characteristics of Autism Spectrum Disorder 
 The most recent report from the Center for Disease Control’s (CDC) Autism and 
Developmental Disabilities Monitoring Network (ADDM) estimated that 1 in 68 children 
are identified with autism spectrum disorder (ASD; Miller et al., 2013). The current 
definition of ASD is far from what Leo Kanner first established in 1943 when he 
described 10 children to have “extreme autistic aloneness,” as well as echolalia, 
preference for sameness, and repetitive behaviors. This description was coined “early 
infantile autism” (Kanner, 1943).  In 1944, Hans Asperger identified a similar disorder, 
“Asperger’s,” as he described children presenting as “little professors” who lacked skills 
in social interactions but did not appear to have the same extreme behavioral difficulties 
as the children described by Kanner. This description would later be recognized as 
Asperger’s syndrome (Wing, 1981).  
In 1980, the American Psychological Association published the Diagnostic and 
Statistical Manual of Mental Disorders, Third Edition (American Psychiatric Association, 
1980). This was the first DSM to recognize autism as a formal disorder (Baker, 2013). 
Labeled as infantile autism, it was said to be distinctively different from schizophrenia, 
displayed prior to the age of 2 ½ years, and marked by symptom criteria in three 
domains: reduced social responsiveness, impaired communication skills, and odd 
environmental responses (American Psychiatric Association, 1980; Baker, 2013). The 
criteria for autism changed again in 1987 with the DSM-III revision (DSM-III-R), as did 
the name, which was changed to autistic disorder (American Psychiatric Association, 
1987; Baker, 2013). The criteria for autistic disorder required individuals to meet 8 of the 
16 criteria in the three different domains and included a new category for children who 
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met some but not all of the diagnostic criteria. This category was called pervasive 
developmental disorder, not otherwise specified (PDD-NOS). The DSM-III-R also 
removed the requirement that symptoms must be present prior to the age of 3 years 
(American Psychiatric Association, 1987; Baker, 2013). The DSM-IV further revised the 
criteria for pervasive developmental disorder to include autistic disorder, PDD-NOS, 
Asperger’s disorder, and Rett’s syndrome (American Psychiatric Association, 1994). 
These revisions are important to our understanding of ASD because they provide further 
evidence that, as clinicians and researchers, we have been struggling to define autism 
since the 1980s. The various revisions have had an impact on individuals with the 
diagnosis and the process of researching the disorder (Baker, 2013; Cottle, McMahon, & 
Farley, 2016).  
In the DSM-5, autism is currently referred to as autism spectrum disorder under 
the category of neurodevelopmental disorders and defined by two diagnostics categories: 
deficits in social communication and social interaction; restricted, repetitive patterns of 
behavior, interests, or activities. While impairment must be present in early development, 
it might not become apparent until social demands increase with age (American 
Psychiatric Association, 2013). The DSM-5 no longer includes the diagnoses Asperger’s 
syndrome or PDD-NOS and requires clinicians to specify the level of support required by 
the individuals and whether or not the diagnosis is accompanied by an additional 
language impairment or intellectual disability. Finally, the DSM-5 revisions removed the 
stipulation that attention deficit hyperactivity disorder (ADHD) and obsessive 
compulsive disorder could not be diagnosed along with a pervasive developmental 
disorder (American Psychiatric Association, 2013). 
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ASD prevalence is significantly higher in males than females. While ASD’s 
underlying etiology is currently unknown, several environmental factors and genetics 
findings are associated with increased risk for developing ASD (Bailey et al., 1995; 
Bakian, Bilder, Coon, & McMahon, 2015; Bilder, Pinborough-Zimmerman, Miller, & 
McMahon, 2009; Muhle, Trentacoste, & Rapin, 2004). There are no known cures for 
ASD but behaviorally-based interventions, such as those based on applied behavior 
analysis and pivotal response training, have been determined effective in reducing 
symptom severity (American Psychiatric Association, 2013; Rogers & Vismara, 2008). 
There is no specific medication to reduce core features of ASD, but co-occurring 
conditions are frequently targeted with psychotropic medications (Buck et al., 2014). 
The measured prevalence of ASD has been increasing over the last few decades 
(Centers for Disease Control, 2014). While environmental factors may be influencing this 
trend, other factors such as case definition, increased awareness, and improved diagnostic 
assessment tools may also contribute to this phenomenon (Miller et al., 2013). 
 
Outcomes in Adulthood 
Until relatively recently, autism was characterized by its early onset in childhood 
and conceptualized as a childhood disorder. As more children were identified with ASD, 
early diagnosis and treatment quickly became the focus of research (Baker, 2013; Cottle, 
McMahon, & Farley, 2016). ASD studies that included adults were few and often had 
small sample sizes relative to the research focused on children at-risk for or diagnosed 
with ASD (Cottle, McMahon, & Farley, 2016). ASD in adulthood is now emerging as a 
significant focus of research (Bilstedt, 2005; Cottle, McMahon, & Farley, 2016; Farley et 
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al., 2009; Roux, Shattuck, Rast, Rava, & Anderson, 2015). Research on adult outcomes is 
typically reported across several different domains: cognitive ability, independence, 
social relationships, education and employment, and symptom impairment or behavior 
and comorbid conditions (Eaves & Ho, 2008; Farley et al., 2009; Roux, 2014). These 
studies remain largely descriptive but some compare adults with ASD to adults with other 
disabilities or typically developing adults (Barneveld et al., 2014). Rating systems have 
been established to reflect overall functioning achieved by adults with ASD (Billstedt, 
Gillberg, & Gillberg, 2005; Eaves & Ho, 2008; Engstrom, Ekstrom, & Emilsson, 2003; 
Farley et al., 2009). The following describes the existing literature by specific domains 
and overall functioning.  
 
Cognitive Ability   
The most common reporting of cognitive abilities in adults with ASD has been 
change in abilities across longitudinal or follow-up studies. Magiati, Tay, and Howlin 
(2014) reviewed the literature on cognitive functioning in adulthood. While the majority 
of studies included in the review reported that cognitive abilities of individuals with ASD 
remain stable over time, individual scores show large amounts of variability, with some 
individuals showing either increases or decreases greater than one standard deviation 
(Farley et al., 2009; Sigman & McGovern, 2005). More specifically, Sigman and 
McGovern (2005) reported that some individuals displayed declines in IQ score over 
time. Howlin, Goode, Hutton, and Rutter (2004) and Mawhood, Howlin, and Rutter 
(2000) both reported significant increases in cognitive ability, specifically verbal IQ, in a 
small percentage of participants. Gains in cognitive ability were typically associated with 
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better adult outcomes (Farley et al., 2009) and individuals with more significant autism 
symptomatology were found to have lower cognitive abilities, which remained stable or 
decreased over time (Cederlund, Hagberg, Billstedt, Gillberg, & Gillberg, 2008).  
 
Independence  
Research is showing that a large majority of adults with autism fail to achieve full 
independence in adulthood, with many requiring familial or social support (Farley et al., 
2009). In 2014, Buescher, Cidav, Knapp, and Mandell reported that the lifetime cost of 
supporting an individual with an intellectual disability and ASD was $2.4 million dollars. 
To support an individual without an intellectual disability and ASD was $1.4 million 
dollars. Residential care or support during adulthood and loss of individual productivity 
were noted as significant contributors to overall cost (Buescher et al., 2014). Adults with 
ASD typically require a high level of assistance (Engstrom, Ekstrom, & Emilsson, 2003; 
Farley et al., 2009). Some adults live independently, but a large majority live with 
parents, family members, or within group homes (Eaves & Ho, 2008; Engstrom, 
Ekstrom, & Emilsson, 2003; Farley et al., 2009). A large majority of adults who live 
independently receive a large amount of support from local family members (Farley et 
al., 2009). In addition to relying on familial support, many adults with ASD receive 
support from public funding sources, such as vocational rehabilitation, supplemental 
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Social Relationships  
Social relationships are an innate factor of adult life, but studies show that adults 
with ASD fail to participate in typical social relationships in adulthood. Adults with ASD 
without intellectual disability rarely engage in romantic relationships (Engstrom, 
Ekstrom, & Emilsson, 2003; Farley et al., 2009). In a follow-up study of more 
cognitively able adults, 44% of adults had never dated and only 19% of adults had 
engaged in long-term romantic relationships, including marriage (Farley et al., 2009). 
Eaves and Ho (2008) found that 33% of adults with ASD were active in friendships and 
friendly social activities. Farley et al. (2009) reported similar findings and suggested that 
a large majority of adults participated in social or organized activities, such as church 
activities or Special Olympics sports (Farley et al., 2009). Given that ASD is marked by 
social communication and interaction deficits, some of these findings might not be 
surprising; but, like employment, some studies show lower rates of social relationships 
and activities when adults with ASD are compared to adults with other disabilities. When 
compared to adults with ID, emotional disturbance, or learning disorders, adults with 
ASD were more likely to be social isolated and show irregular social functioning 
(Orsmond, Shattuck, Cooper, Sterzing, & Anderson, 2013), adding to the evidence that 
adults with ASD show impairments in their social relationships.  
 
Symptom Impairment, Behavior, and Comorbid Conditions   
Self-injurious behavior (SIB), social difficulties, and disruptive behavior are all 
common symptoms studied in childhood. Several researchers investigated whether or not 
these difficulties were still present in adulthood. Kats, Payne, Parlier, and Piven (2013) 
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investigated specifically older adults with ASD and ID when compared to older adults 
with just ID. As adults age into later adulthood, it is unknown as to what difficulties they 
will encounter and what support will be needed (Cottle, McMahon, & Farley, 2016; 
Wright, Brooks, D’Astous, & Grandin, 2013). Kats et al. (2013) found that 40-60% of 
adults with ASD and ID required support to manage SIB and disruptive behavior. It was 
reported that SIB and disruptive behaviors doubled in adults with ASD and ID when 
compared to adults with ID alone (Kats et al., 2013). While many studies report similar 
symptom impairment or lessened symptom severity in adulthood (Farley et al., 2009), 
several studies have noted a phenomenon where individuals with ASD show a decrease 
in symptom severity in later adolescence but then experience an increase in symptom 
severity in early adulthood (Vannucchi et al., 2014; Wei, Wagner, Hudson, Yu, & 
Shattuck, 2015). Vannucchi and colleagues (2014) referred to this concept as the setback 
phenomenon, where individuals show an increase in social difficulties, preference for 
sameness, and strict limitation for interests. The authors hypothesized that comorbid 
psychiatric conditions could be worsening at this time, increasing the impact of the 
setback (Vannucchi et al., 2014). Many studies have reported comorbid medical and 
psychiatric conditions (Buck et al., 2014; Howlin, 2000; Jones et al., 2015). More 
common comorbid medical conditions in adults with ASD were found to be constipation, 
obesity, insomnia, and seizures (Jones et al., 2015). Several studies have also reported 
common co-occurring psychiatric disorders, such as depression, anxiety, and ADHD 
(Buck et al., 2014; Howlin, 2000). Given the impact of the co-occurring psychiatric 
conditions and their relevance to this project, these co-occurring disorders will be 
discussed in further detail in a later section.  
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Education and Employment   
Studies on outcomes in adulthood consistently report that less than half of adults 
with ASD are currently or ever have been employed (Eaves and Ho, 2008; Farley et al., 
2009; Howlin, 2000). In addition, a large majority of adults with ASD have lost jobs, are 
employed in relatively low-level positions, and require on-the-job supports (Eaves & Ho, 
2008; Farley et al., 2009; Howlin, 2000). One striking factor is that not only are adults 
with ASD relatively underemployed compared to typically developing adults but also 
when compared to adults with other disabilities (Barneveld et al., 2014; Roux et al., 
2013). These findings occur among adults with ASD with and without intellectual 
disability (Baldwin, Costly, & Warren, 2014; Farley et al., 2009). Baldwin et al. (2014) 
investigated the work experiences of adults with Asperger’s syndrome or High 
Functioning ASD diagnoses. They found that almost half of the adults were overeducated 
for their job and more than half of the adults required some support in their employment 
setting (Baldwin et al., 2014).   
 Along with being underemployed, adults with ASD are not enrolling in 
postsecondary education or completing advanced degrees (Baldwin et al., 2014; Farley et 
al., 2009; Roux et al., 2013; Wei et al., 2015). Farley et al. (2009) reported that 39% of 
the more cognitively able participants in their sample went on to receive postsecondary 
education. Wei et al. (2015) investigated education and employment attainments of adults 
2, 4, and 6 years after high school graduation. Two years after high school, most of the 
young adults were not enrolled in postsecondary education and were unemployed. The 
unemployment rates dropped 4 years after high school but then increased again 6 years 
after graduation. Overall, 29% of participants were reported to be continuously or 
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increasingly disengaged from education or employment after high school graduation 
(Wei et al., 2015). Despite many adults with ASD being cognitively able, achieving 
higher education, and obtaining some employment opportunities, rates of employment in 
adults with ASD rarely increase above 50% (Baldwin et al., 2014; Henninger &Taylor, 
2013; Roux et al., 2013; Vogeley, Kirchner, Gawronski, van Elst, & Dziobk, 2013; Wei 
et al., 2015). As of today, very few high-quality vocational interventions exist and most 
lack strong methodology or do not yield consistently positive results (Taylor et al., 2012). 
Vogeley et al. (2013) suggested that the assessment tools used prior to an intervention 
need improvement and interventions might be more effective if individual’s preference 
were better matched with the requirements of the work place. There is currently a high 
need to investigate the employment difficulties and potential barriers to employment 
experienced by adults with ASD to develop interventions that improve outcomes of 
adults with ASD (Barneveld, Taylor, Henninger, Mailick; 2015; Roux et al., 2013; 
Vogeley et al., 2013; Wei et al., 2015).  
 Overall, the literature base thus far shows that rates of employment in adults with 
ASD tend to be lower than when compared to typically developing peers and adults with 
other developmental disabilities. Several studies have shown that even adults with 
average or above average IQ are unable obtain gainful employment (Farley et al., 2009; 
Wei et al., 2015). Adults with ASD are shown to have difficulty obtaining and 
maintaining employment, but this is also true for adults with other psychiatric conditions. 
Mojtabai et al. (2015b) reported that adults with lifetime disorders had reduced odds of 
being employed than their counterparts. Employment or student status at initial 
evaluation predicted employment at the follow-up assessment, but lifetime history of 
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anxiety was found to impact one’s employment abilities (Mojtabai et al., 2015b). In a 
study of employment status among veterans, researchers found that participants with 
depression or anxiety were less likely to be employed. They participants reported more 
employment barriers and had reduced levels of work performance (Zivin et al., 2016). A 
Norwegian study of health and unemployment was interested in this same concept, as 
much of the current literature discusses how unemployment influences health. 
Researchers found that participants with anxiety were at increased risk of unemployment 
(Kaspersen et al., 2016). Given that typically developing adults with anxiety experience 
difficulty maintaining employment, it is likely that co-occurring anxiety also negatively 
impacts adults with ASD, a population of individuals who appear to have high rates of 
co-occurring anxiety.  
 
Overall Outcomes  
In an attempt to quantify outcomes in adulthood, many researchers created and 
use outcome ratings to represent overall outcomes in adults with ASD. These ratings 
were based on social relationships, education or employment, and independent living 
(Eaves & Ho, 2008; Farley et al., 2009). Eaves and Ho (2008) reported that 21% of adults 
obtained an overall outcome rating (OOR) of good or very good. None of the adults 
received a poor rating and it was noted that emotional difficulty was very common in the 
participants (Eaves & Ho, 2008). Another study reported poor ratings in 78% of 
participants and stated that childhood IQ and phrase speech were positively correlated 
with better adult outcome (Billstedt, Gillberg, & Gillberg, 2005). Lastly, Farley et al. 
(2009) reported better overall outcomes, with 48% of participants obtaining very good or 
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good ratings. Farley et al. (2009) commented on the high level of social and religious 
support provided to the individuals in the community, a factor that may improve these 
ratings (Farley et al., 2009). While these rating systems are beneficial, they have large 
measurement errors, are not standardized, and do not incorporate the individual’s 
perspective (Henninger & Taylor, 2013). Barneveld et al. (2014) measured Quality of 
Life (QoL) in adults with ASD and compared these scores with those of adults with 
attention deficit hyperactivity disorder, disruptive behavior disorders, and affective 
disorders. QoL was worse in adults with ASD. These adults had lower levels of education 
and fewer paid employment positions; a large proportion received supplemental security 
income. Although many individuals with ASD in this study were highly educated, they 
still reported lower QoL (Barneveld et al., 2014). Some studies report relatively positive 
outcomes in adults with ASD (Farley et al., 2009), but the large majority of studies 
suggest that adults with ASD are not reaching their full potential and it is unknown as to 
why (Eaves & Ho, 2008; Wei et al, 2015).  
 
Comorbid Psychiatric Conditions 
Through our recently improved understanding of ASD symptoms and diagnostic 
tools, it has come to the attention of researchers and clinicians that individuals with ASD 
frequently suffer from co-occurring psychiatric disorders (Buck et al., 2014; de Bruin, 
Ferdinand, Meester, de Nijs, & Verheij, 2007; Howlin, 2000; Roy, Prox-Vagedes, 
Ohlmeier, & Dillo, 2015). Estimates of at least one co-occurring condition in individuals 
with ASD range from 5-80% (de Bruin at al., 2007). The most common co-occurring 
psychiatric conditions are reported to be mood disorders, ADHD, and anxiety (Bjorn et 
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al., 2009; Buck et al., 2014; de Bruin et al., 2007; Lungeard et al., 2011). While co-
occurring psychiatric conditions are observed in individuals of all ages, the focus of this 
project is on co-occurring conditions in adults. The literature shows similar findings 
between children and adults in regards to depression, anxiety, and obsessive-compulsive 
disorder (Bakken et al., 2010; Buck et al., 2014; Croen et al., 2015; Hofvander et al., 
2009). Although ASD can greatly impact the outcomes of an adult with ASD, comorbid 
conditions could worsen symptoms of ASD, making optimum outcomes difficult for 
individuals to achieve (Vannuchi et al., 2013).  
 
Anxiety 
Anxiety disorders are said to be the most common co-occurring disorders in 
individuals with ASD. Prevalence reports of co-occurring psychiatric conditions vary 
across studies, but all concur that anxiety disorders frequently co-occur in individuals 
with ASD (Bakken et al., 2010; Buck et al., 2014; Croen et al., 2015; Hofvander et al., 
2009; Roy et al., 2015).  
 Anxiety disorders are one of the most common disorders diagnosed in the general 
population with a lifetime prevalence of 28.8% (Bandelow, Lichte, Rudolf, Wiltink, & 
Beutel, 2014; Kessler et al., 2012; Kessler, Chiu, Demier, Merikangas, & Walters, 2005). 
Commonly developed in childhood, the different anxiety disorders (Table 1) are 
differentiated by a different fear or worry.  
To meet criteria for a clinical anxiety disorder diagnosis, individuals must present 
with symptoms of excessive and persistent worry or fear that is determined to be out of 
proportion for the situation. These disorders are typically stress induced marked by  














Disorder Diagnostic features 
separation anxiety disorder Fear or anxiety of separating from attachment figures or home 
selective mutism Failure to initiate speech or reciprocally respond 
when spoken to in social situations 
specific phobia  Fear in the presence of a specific object or 
situation 
social anxiety disorder  Fear of social situations in which the individual 
is feared of being judged 
panic disorder  Panic attacks that are unexpected and recurrent 
panic attack specifier  Four or more physical symptoms occur in an 
abrupt surge of fear or discomfort, lasting 
several minutes 
agoraphobia  Fear triggered by being exposed to or 
anticipating: using public transportation, being 
in open spaces, being in enclosed spaces, 
standing in line, being out of the home 
generalized anxiety 
disorder 
Excessive worry about numerous events or 
activities 
substance/medication-
induced anxiety disorder 
Panic or fear due to the effects of a substance 
anxiety disorder due to 
another medical condition 
Anxiety best explained by effect of another 
medical condition 
other specified anxiety 
disorder 
Symptoms are characteristic of an anxiety 
disorder but does not meet full criteria and the 




Symptoms are characteristic of an anxiety 
disorder but does not meet full criteria and the 
clinician chooses not to specify why the criteria 
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physical or psychological symptoms. Physical symptoms of anxiety include stomach 
aches, palpitations, sweating, shakiness, restlessness, and muscle tension. Psychological 
symptoms include feelings of danger, constant tension, worry, sleep disturbance, 
irritability, or cognitive ideation (American Psychiatric Association, 2013; Ghaziuddin, 
2008).  The National Comorbidity Survey Replication reported that 18.1% of adults 
surveyed presented with any anxiety disorder. The most commonly diagnosed anxiety 
disorders were specific phobia (8.7%), social phobia (6.8%), posttraumatic stress disorder 
(3.5%), generalized anxiety disorder 2.1%), and panic disorder (2.7%) (Kessler et al., 
2012). A follow-up study on the lifetime prevalence of anxiety disorders in individuals 
aged 18 to 64 showed the following prevalence rates: specific phobia (13.8%), social 
phobia (13.0%), posttraumatic stress disorder (8.0%), generalized anxiety disorder 
(6.2%), and panic disorder (5.2%). The overall prevalence rate for any lifetime anxiety 
disorder was 33.7% (Kessler et al., 2012).  
Anxiety is diagnosed using various rating scales and based on criteria described in 
the DSM-5 or the International Classification of Diseases, Tenth Revision (ICD-10; 
Bandelow et al., 2014). There is a large amount of research on anxiety disorders, in areas 
of both diagnosis and treatment. Individuals with acute and persisting anxiety frequently 
experience life impairments (Kessler et al., 2012), as well as lower quality of life than 
adults without anxiety (Barrerra et al., 2009).  
 
Co-occurring Anxiety in Children With ASD 
The majority of the available research on co-occurring anxiety in individuals with 
ASD has been conducted with children. Pediatric research on co-occurring anxiety 
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provides a context in which to study anxiety in adults with ASD. The research thus far 
has focused on describing the nature of anxiety in children with ASD, particularly how 
co-occurring anxiety disorders manifest in children (Hallett, Lecavelier, Sukhodolsky, & 
Cipriano, 2013; Kerns et al., 2014: Kerns & Kendall, 2013; Renno & Wood, 2013; Ung, 
Selles, Small, & Storch, 2014). Given the overlap of symptoms between anxiety and 
ASD, the goal of many research studies has been to determine whether common anxiety 
disorders seen in individuals with ASD exist independently or if they are simply 
manifestations of symptoms of ASD (Kerns & Kendall, 2013; Rodgers, Glod, Connolly, 
& McConachie, 2012). In addition to confirming that anxiety is a separate, co-occurring 
disorder, researchers are investigating whether or not the manifestation of anxiety in 
individuals with ASD is atypical or similar to that of children without ASD (Kerns & 
Kendall, 2013; Ozsivadjian, Hibberd, & Hollocks, 2014; Renno & Wood, 2013).  
Several studies reported that higher levels of anxiety were found in children 
without comorbid intellectual disability, functional language abilities, and overall higher 
verbal comprehension index scores (Dubin, Lierberman-Betz, & Lease, 2015; Gotham, 
Brunwasser, & Lord, 2015; Hallett et al., 2013; Kerns et al., 2015; Kerns et al., 2014; 
Ung et al., 2014). Co-occurring anxiety was found in 41.7% of a sample of children 
identified to have high functioning ASD and higher cognitive abilities (Ung et al., 2014). 
When compared to children and adolescents without ASD, children with ASD displayed 
a higher prevalence of anxiety regardless of measure (Bitsika & Sharpley, 2015). Since 
co-occurring anxiety in youth was found to be more prevalent in children with functional 
language abilities and without accompanying intellectual disability, some suggest that the 
presence of anxiety is associated with lesser ASD severity (Hallett et al., 2013; Kerns et 
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al., 2015). However, children with co-occurring anxiety disorders were also more likely 
to display self-injurious behaviors and symptoms of depression (Kerns et al., 2015). 
Greater feelings of loneliness are associated with higher levels of self-reported anxiety 
(White & Roberson-Nay, 2009). Lastly, anxiety severity has been associated with greater 
functional impairment in children with ASD, suggesting that children with ASD and 
greater levels of anxiety experience worsened impairment that requires additional 
intervention (Ung et al., 2014).  
The majority of screening or assessment tools for psychiatric conditions have only 
been validated in typically developing children, making it difficult to diagnose anxiety in 
children with ASD. Because of this, several researchers have evaluated the reliability of 
assessment tools used with children with ASD. Wigham and McConachie (2014) 
systematically reviewed the properties of tools used to measure co-occurring anxiety. The 
Spence Children’s Anxiety Scale, Revised, Revised Children’s Anxiety and Depression 
Scale, and the Screen for Child Anxiety Related Emotional Disorders were found to have 
good psychometric properties in children with ASD (Wigham & McConachie, 2014). 
Many studies have used parent reports or clinical parent interviews to measure anxiety in 
children with ASD. Ozsivadjian, Knott, and Magiati (2012) compared self-report 
measures of anxiety to parent-reported symptoms with the hopes of determining 
appropriate measures to demonstrate treatment outcomes. Kaat and Lucavelier (2015) 
also tested the validity and reliability between parent and child versions of the Revised 
Child Anxiety and Depression Scale and Multi-Dimensional Anxiety Scale. Both studies 
demonstrated good agreement between children with ASD and their parents on measures 
of anxiety, demonstrating the usability of these measures for prevalence or treatment 
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studies (Kaat & Lucavelier, 2015; Ozsivadjian, Hibberd, & Hollocks, 2014).  
Self and caregiver reports of anxiety have proven to be reliable and valid for 
assessing anxiety in children with ASD, but it is unknown as to whether or not these 
children experience the physiological symptoms of anxiety in a similar manner as 
children without ASD. Lanni, Schupp, Simon, and Corbett (2012) evaluated 
physiological stress and reported experiences of anxiety in children with and without 
ASD. Interestingly, the children with and without ASD reported similar levels of anxiety 
throughout the experiment, but the children with ASD showed stable levels of cortisol, 
unlike their peers who displayed an increase (Lanni et al., 2012). Sharpley, Bitsika, 
Agnew, and Andronics (2015) also found that cortisol levels and reports of anxiety 
among children with ASD were consistent across time points; however, the cortisol levels 
and levels of reported anxiety were inconsistent (Sharpley et al., 2015). In addition to 
reduced cortisol levels, Hollocks, Howlin, Papadopoulos, Khondoker, and Simonoff 
(2014) found reduced heart rates in response to psychosocial stress in children with 
increased levels of anxiety. All of these studies suggest that stress responses in children 
with ASD are more complicated than typically developing children and the stress 
mechanisms in children with ASD could be contributing to higher levels of anxiety 
(Hollocks et al., 2014; Lanni et al., 2012; Sharpley et al., 2015).  
Finally, the high prevalence of anxiety seen in children with ASD and associated 
difficulties has inspired a great deal of treatment research with the hopes of reducing 
symptoms of ASD. Wood et al. (2015) have conducted several studies evaluating the 
efficacy of cognitive behavioral therapy to reduce symptoms of anxiety in children and 
early adolescents. The majority of these studies found cognitive behavioral therapy to be 
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efficacious. The most recent study by Wood et al. (2015) demonstrated efficacy of 
cognitive behavioral therapy in a randomized control trial. Seventy-nine percent of the 
treatment group displayed clinical improvements compared to 28.6% of the waitlist 
group. Although improvements were seen based on a global improvement scale and 
parent-reported symptoms, self-report measures did not yield significant changes between 
groups (Wood et al., 2015). Kreslins, Robertson, and Melville (2015) reviewed the 
effectiveness of psychosocial interventions for children with ASD and co-occurring 
anxiety. The majority of studies demonstrated greater efficacy of psychosocial 
interventions when compared to treatment-as-usual or waitlist controls. Although the 
majority of measures in these studies showed decreases in anxiety, self-reported 
outcomes measures were less likely to show significant changes in posttreatment 
symptoms (Kreslins, Robertson, & Melville, 2015). The current availability of literature 
demonstrates the efficacy of psychosocial treatments for children with ASD when 
compared to waitlist or treatment-as-usual groups, but the literature also states the need 
for replication studies, use of larger sample sizes, and comparison to other treatments 
(Kreslins, Robertson, & Melville, 2015; Wood et al., 2015).  
 
Anxiety in Adults With ASD  
The available literature on co-occurring anxiety in children with ASD is rapidly 
increasing and providing avenues in which we can direct research on adults; however, 
there is still relatively little research on adults with ASD and co-occurring anxiety. Early 
studies reported a high prevalence of co-occurring anxiety in adults with ASD (Rumsey, 
Rapoport, & Sceery, 1985; Szatmari, Bartolucci, & Brenner, 1989; Tantam, 1991; Wing, 
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1981); but, surprisingly, after these studies in the 1980s and early 1990s, the reports of 
co-occurring psychiatric disorders were almost nonexistent. The most recent prevalence 
studies suggest that anxiety disorders are the most common co-occurring disorders in 
adults with ASD (Bakken et al., 2010; Buck et al., 2014; Croen et al., 2015; Hofvander et 
al., 2009; Roy et al., 2015). Some researchers have focused on the area of co-occurring 
social anxiety in adults with ASD (Maddox & White, 2015; Swain et al., 2015) and 
others have compared anxiety in individuals with ASD to that in individuals with 
intellectual disability (Bakken et al., 2010; Gillot & Standen, 2007) or typically 
developing adults (Hare et al., 2015). Today, the majority of the adult literature presents 
on prevalence (Bakken et al., 2010; Buck et al., 2014; Croen et al., 2015; Hofvander et 
al., 2009; Roy et al., 2015), and shows a large amount of variation in the type of study 
and reporting of these diagnoses.  
Maddox and White (2015) and Lugnegard, Hallerback, and Gillberg (2011) both 
reported that social anxiety disorder was the most common anxiety disorder diagnosis in 
adults with ASD (Lugnegard, Hallerback, & Gillberg, 2011; Maddox & White, 2015). In 
the most recent study of co-occurring social anxiety in adults with ASD, Maddox and 
White (2015) examined the prevalence and clinical presentation of social anxiety disorder 
compared to adults without ASD. They found that a large proportion of adults with ASD 
also met criteria for social anxiety disorder and that the presentation of social anxiety 
disorder in these individuals was different from that of adults with social anxiety disorder 
without ASD (Maddox & White, 2015). These authors, along with Swain, Scarpa, White, 
and Laugeson (2015), raised in their discussion the impact of decreased emotional 
regulation and hypersensitivity to negative social interactions. Swain et al. (2015) found 
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that increased social anxiety was linked to difficulties with emotion regulation. Maddox 
and White (2015) also discussed the complexity of social anxiety, particularly the 
interaction between social deficits and the reduced ability to process negative social 
situations. It was suggested that adults with ASD are potentially more aware of their 
social deficits and have more negative social interactions; however, they lack the ability 
to regulate their emotions during or after social situations (Maddox & White, 2015; 
Swain et al., 2015). Both emphasized the need for additional research in the area of social 
anxiety in adults with ASD to improve diagnosis and subsequent treatment (Maddox & 
White, 2015; Swain et al., 2015). 
In addition to reporting on overall prevalence in samples of adults with ASD, 
several studies have compared co-occurring anxiety in adults with ASD to anxiety in 
individuals with intellectual disability (Bakken et al., 2010; Gillot & Standen, 2007). 
Bakken et al. (2010) investigated psychiatric disorders in adolescents and adults with 
ASD and adults with intellectual disability. Using a checklist modified for individuals 
with autism, they found that the largest group differences were in the prevalence of co-
occurring anxiety, with adults with ASD presenting with higher rates of anxiety (Bakken 
et al., 2010). Gillot and Standen (2007) used a modified version of the Spence Children’s 
Anxiety Scale, Parent to compare anxiety disorders in adults with ASD and intellectual 
disabilities to adults with intellectual disabilities without ASD. The Spence provided 
subscales of panic attack and agoraphobia, separation anxiety, physical injury fears, 
social phobia, obsessive-compulsive disorder, and generalized anxiety disorder. A 
measure of stress was also administered to both groups. The adults with ASD in this 
study displayed higher rates of co-occurring anxiety, with panic and agoraphobia, 
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separation anxiety, obsessive-compulsive disorder, and generalized anxiety disorder 
being the most common. The group with autism also displayed more stress, especially 
with change and anticipation (Gillot & Standen, 2007). Individuals with intellectual 
disability commonly have difficulty completing standardized rating forms, so both 
studies utilized caregiver measures. However, both studies also emphasized the need to 
obtain self-reports of anxiety (Bakken et al., 2010; Gillot & Standen, 2007). 
A large variety of study methodologies and measurement tools have recently been 
used to describe anxiety in adults with ASD. Some studies report current symptom 
presentation (Lugnegard, Hallerback, & Gillberg, 2011) and others present lifetime 
comorbidity of these diagnoses (Buck et al., 2014; Hofvander et al., 2009). Lugnegard, 
Hallerback, and Gillberg (2011) reported that 50% of the sample presented with co-
occurring anxiety disorders and Hofvander et al. (2009) reported that mood and anxiety 
disorders were the most common in their study of adults with normal cognitive ability. 
Mazefsky, Folstein, and Lainhart (2008) investigated prevalence of mood disorders in 34 
adults with ASD and their families. Almost 90% of that sample was identified as having 
at least one mood or anxiety diagnosis as measured by The Schedule of Affective 
Disorders and Schizophrenia – Lifetime Version. Phobias and generalized anxiety 
disorders were the most common, affecting 59% and 41% of the sample, respectively 
(Mazefsky, Folstein, & Lainhart, 2008). Overall, anxiety disorder prevalence rates among 
adults with ASD vary significantly across studies and few large-scale studies have been 
conducted. 
In addition to varying prevalence rates, various tools have been used to measure 
comorbid psychiatric conditions, such as the Structured Clinical Interview for DSM-IV 
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Axis I Disorders (Lugnegard, Hallerback, & Gillberg, 2011), the Mini Psychiatric 
Assessment Schedules for Adults with Developmental Disabilities (Mini PAS-ADD; 
Buck et al., 2014), Hospital Anxiety and Depression Scale (Hare et al., 2015), Anxiety 
Disorders Interview Schedule for DSM-IV: Social Phobia Module (Maddox & White, 
2015), parental or caregiver report of historical lifetime diagnoses (Buck et al., 2014; 
Hofvander et al., 2009), and medical billing codes from electronic healthcare records 
(Croen et al., 2015). Overall, these studies report the findings that anxiety appears to be 
co-occurring as a separate diagnosis in adults with ASD, but we have limited research 
evidence suggesting the overall prevalence and manifestation of the disorder, as well as a 
lack of evidence-based best practices for diagnosing and measuring the presence and 
severity of anxiety disorders in adults with ASD.  
Lastly, it is important to note that the studies described above, specifically those 
that focus on prevalence of any anxiety disorder, have relatively small samples sizes 
(Figure 1). Ghaziuddin (2008) presented prevalence on a sample of 28 participants. Both 
Bakken et al. (2010) and Joshi et al. (2013) had a sample size of about 60 (N = 62, 
Bakken et al., 2010; N = 63, Joshi et al., 2013). The largest samples were by Buck et al. 
(2014) and Lever and Geurts (2016), with samples sizes of 129 and 247, respectively. 
Croen et al. (2015) ascertained the largest sample, with a sample of 1507 participants. 
The small sample sizes in these studies reflect on the limited scope of prevalence 








Figure 1. This figure depicts the both sample sizes and current estimates of co-occurring 
anxiety in adult with ASD. 
 
Measuring Prevalence of Psychiatric Conditions 
Given the difficulty in administering semistructured interviews to large samples 
of adults with ASD, the field is taking advantage of the ease and availability of electronic 
healthcare records to report on co-occurring psychiatric conditions (Croen et al., 2015). 
While studies using validated questionnaires have demonstrated prevalence rates of  
co-occurring psychiatric conditions and our evidence supports the clinical presence of 
these conditions, we have very few large-scale, epidemiological studies (Hare et al.; 
2015; Maddox & White, 2015; Mazefsky, Folstein, & Lainhart, 2008). Croen et al. 
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codes from electronic health records. While this method is time and cost efficient, there 
are mixed reports as to the validity of these data when compared to standardized 
assessments (Croen et al., 2015). Several other methods have been used to investigate the 
prevalence of psychiatric conditions (Centers for Disease Control, 2014; Kessler et al., 
2005) and medical conditions (Campbell et al., 2011; Dismuke, 2005; Thiru, Hassey, & 
Sullivan, 2003); their strengths and weaknesses are presented below.  
 The National Comorbidity Survey Replication (NCS-R) is one of the largest and 
most cited studies investigating the prevalence of comorbid psychiatric conditions in 
adults. This study utilized a face-to-face structured clinical interview to assess for 
comorbid psychiatric conditions in over 14,000 participants. While this study used a gold 
standard assessment tool to measure prevalence, it was incredibly expensive and 
exhaustive to conduct (Kessler et al., 2005). The majority of autism studies do not have 
the type of funding resources to carry out this type of research study (Croen et al., 2015; 
Kohane et al., 2011). The Centers for Disease Control (CDC) uses The Autism and 
Developmental Disabilities Monitoring (ADDM) methodology to survey the prevalence 
of ASD in children. The ADDM methodology is an in-depth and comprehensive record 
review, where information based on the DSM-IV is abstracted and coded for potential 
ASD classification. While ICD-9 codes are used in the first wave of ascertainment, 
further record review and data abstraction are completed to determine case status 
(Centers for Disease Control, 2014).  
The Centers for Disease Control (2014) and Kessler et al. (2005) used more 
extensive measures to examine prevalence of autism spectrum disorder, intellectual 
disabilities, and psychiatric conditions, but many studies have used diagnostic billing 
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codes for investigating medical conditions. Campbell et al. (2011) compared prospective 
in-person assessments of medical complications following surgery with retrospective 
ICD-9 codes and a record review. The ICD-9 based review captured a large number of 
medical events that had relatively little clinical importance. These events inflated the 
overall incidence rate of complications following surgery (Campbell et al., 2011). 
Dismuke (2005), on the other hand, found that many encounters in an imaging and 
diagnostics lab undercoded in regards to procedures. This was largely because the ICD-9 
procedure codes were not needed for reimbursement. This study demonstrates the 
potential bias in diagnostic code reporting (Dismuke, 2005). Thiru, Hassey, and Sullivan 
(2003) systematically reviewed the quality of electronic medical record data in primary 
care, with hopes of determining if this data type could reliably be used in various types of 
research studies. Articles measuring the quality of data, particularly the completeness or 
accuracy of records, were selected and reviewed. Thiru, Hassey, and Sullivan (2003) 
found it relatively difficulty to measure reliability, validity, and sensitivity of these data 
due to the lack of similarity between studies or thorough reporting of data. They 
determined that these data reflected some consistency but should be used with caution 
(Thiru, Hassey, & Sullivan, 2003).  
As seen, this type of data collection method presents with a high degree of 
variability (Dismuke, 2005; Hogan & Wagner, 1997; Thiru, Hassey, & Sullivan, 2003). 
Psychiatric conditions are by nature more difficult to assess and could be biased by 
clinician preference, hospital setting, or documentation practices (Croen et al., 2015; 
Kohane et al., 2011). The use of International Statistical Classification of Diseases and 
Related Health Problems, Ninth Revision (ICD-9) codes for surveillance research is 
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beneficial, as these codes have been sufficiently reviewed and described, but these codes 
could be used to describe or bill for symptoms rather than actual diagnoses. While there 
is potential for bias, the utilization of ICD-9 diagnostic codes to investigate prevalence 
could provide the opportunity for a strong exploratory study, which could lead into more 
detailed studies (Kohane et al., 2011).  
 
The Proposed Study 
It is overwhelmingly clear that adults with ASD are not reaching optimal adult 
outcomes and individuals with ASD are experiencing high rates of co-occurring 
psychiatric conditions, specifically anxiety. Research on co-occurring anxiety in children 
with ASD has greatly increased over the years, but there is still little known about co-
occurring anxiety disorders in adults with ASD and the impact this debilitating comorbid 
condition has on adult outcomes. There are several limitations of the literature base thus 
far. Due to the complexity of diagnosing comorbid conditions, many with overlapping 
symptoms, studies using in-person semistructured interviews are limited to small sample 
sizes. In order to gain a larger sample size, several researchers have used survey data 
from medical billing codes in electronic healthcare records. This methodology is utilized 
in other areas of medicine, but while time and cost efficient, it is unclear as to whether 
these records compare to the gold standard of psychiatric condition assessment. The 
current study provides a unique opportunity to compare participant data on co-occurring 
anxiety from a gold standard semistructured interview with data extracted from billing 
codes in electronic healthcare records. The prevalence of co-occurring anxiety will be 
described in this adult population and associations between the presence of comorbid 
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psychiatric condition and adaptive functioning will be measured. 
 
Research Questions 
1. How reliable is the use of diagnostic billing codes from electronic healthcare 
records for describing co-occurring anxiety in adults with ASD?  
2. What are the strengths and weaknesses of billing data for describing co-occurring 
conditions in individuals with ASD?  
3. What is the prevalence of co-occurring anxiety in adults with ASD?  
4. How do the types of anxiety disorders expressed by adults with ASD compare to 
the general population?  
5. What is the association between the presence of co-occurring anxiety in adults 










The aim of this dissertation was to enhance our understanding of co-occurring 
anxiety in adults with ASD and evaluate the validity of using diagnostic billing codes to 
present prevalence of anxiety in this population. Three studies using a large participant 
cohort, with subsequent subcohorts, were conducted. The first study aimed to evaluate 
the validity of using diagnostic billing codes to study the psychiatric status of participants 
with ASD. This growing trend provides a cost- and time-efficient method of surveying 
large samples to improve our understanding of co-occurring anxiety in adults with ASD; 
however, how this information compares to gold standard assessments, such as the Mini 
PAS-ADD, is unknown. This study was unique due to the sample of adults with ASD for 
whom we had both gold standard, semistructured assessments of psychiatric disorders 
and surveillance health data. Diagnostic billing codes were provided by the Utah 
Population Database and compared to the University of Utah’s data that were comprised 
of semistructured interviews and questionnaires. The second study aimed to describe the 
prevalence of anxiety in adults with ASD using survey data from diagnostic billing codes. 
Given the validity found in the diagnostic billing code methodology, this study described 
the prevalence of anxiety in adults with ASD, presented the types of anxiety seen in this 
population, and compared rates of anxiety disorders in adults with ASD to the general 
population. Finally, the third study explored the relationships between co-occurring 





Sample Formulation  
A large sample of participants identified with ASD was ascertained through the 
University of Utah Autism Research Program to conduct the three studies in this 
dissertation. A list of University of Utah Autism Research Program study participants 
classified with ASD (N = 542) was provided to the Utah Population Database (UPDB) to 
be matched for medical record extraction from the two largest healthcare systems in 
Utah: The University of Utah Health Care (UUHSC) and Intermountain Healthcare 
(IHC).  The UPDB also identified matched controls. Twenty-five participants matched to 
the UPDB had no medical record in either system and were subsequently removed from 
the ASD cohort, as there was no available source of healthcare utilization. Four hundred 
ninety-five participants were matched to controls (N = 2,475) with a one to five ratio by 
age, sex, and duration of Utah residence. Twenty-two participants with ASD matched to 
the UPDB and a medical record in either system, but UPDB information was insufficient 
to allow control matching (i.e., inability to determine presence and duration of Utah 
residence for Idaho residents). These 22 participants were included in the larger ASD 
sample but without controls.  The total sample consisted of 2,992 participants. Three 
subsamples of participants, to be described later, were created for each study. Lastly, the 
overall ASD sample included several sets of sibling or parent-child relationships. For 
these familial pairs, the individual with the most complete record/Mini PAS-ADD was 
selected to participate. If no such distinction existed, the participant within the family was 
randomly selected. Subsequently, the total sample included 2,492 participants, 432 




Autism Spectrum Disorder Case Status Identification  
The participants with ASD were ascertained through several recruitment methods 
within the University of Utah Autism Research Program reflecting the protocol of their 
original study (Figure 2). A large portion of the participants was first ascertained in the 
1980s during the University of Utah and University of California, Los Angeles 
surveillance study of autism (N = 489). Two hundred forty-one participants in this 
collaborative study were classified with DSM-III autistic disorder during this time. One 
 
 













hundred thirty-eight did not meet diagnostic criteria. Beginning in 2006, University of 
Utah researchers were interested in the impact of the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric 
Association, 2000) criteria on those participants who did not meet DSM III autistic 
disorder criteria.  The Centers for Disease Control and Prevention’s Autism and 
Developmental Disabilities Monitoring Network methodology was then used to reassess 
these participants. Sixty-four participants were reclassified with DSM-IV-TR criteria. 
The sample, consisting of the original participants identified with ASD and those 
reclassified, were contacted for potential participation in the adult follow-up study (N = 
305). One hundred eleven participants from the adult follow-up study were ascertained 
for this dissertation. 
Participants were also ascertained through the University of Utah Transitions 
Study. This study was conducted to observe diagnostic status, life events, psychiatric 
comorbidity, and adaptive functioning of adolescents with ASD who were transitioning 
into adulthood. Eighty-four participants from that study were aged 18 and over and had a 
completed semistructured psychiatric interview; therefore, they were included in this 
study.  
Lastly, participants were ascertained from several University of Utah Genetics 
studies. These studies were seeking to find genetic variations leading to susceptibility for 
ASD, investigating multiplex/extended pedigrees for familial links, and looking at 
genetic differences in Utah pedigrees. Four hundred thirty-two participants in the genetics 
sample were ascertained for this dissertation. 




connections with community resources and clinics, specifically the Autism Council of 
Utah, the University of Utah Autism Spectrum Disorder Clinic, and the Carmen B. 
Pingree Autism Center of Learning. Approved fliers were distributed at conferences and 
events where families with children with autism or their service providers were likely to 
attend. Databases consisting of participants in previous research studies also provided 
potential cases to contact.  
Participants with ASD from these University of Utah Autism Research Program 
studies were ascertained as a single sample for this dissertation. Inclusion criteria for the 
overall sample consisted of participants identified with ASD and aged 18 years or older. 
Institutional Review Board approval was received from the University of Utah, Utah 
Resource for Genetic and Epidemiologic Research (RGE), and Intermountain Healthcare 
to link these University of Utah Autism Research Program studies’ participants with their 
medical billing code data from the Enterprise Data Warehouses of the University of Utah 
and Intermountain healthcare systems.  
 
Procedures 
The University of Utah Institutional Review Board (IRB) approved the Principal 
Investigator of the University of Utah Autism Research Program, Hilary Coon, Ph.D., to 
access data from the UPDB. IRB approval was received from the University of Utah, 
Utah Resource for Genetic and Epidemiologic Research (RGE), and Intermountain 
Healthcare to link University of Utah Autism Research Program studies’ participants 
with their medical billing code data from the Enterprise Data Warehouses of the 





 This dissertation consisted of three retrospective cohort studies on adults with 
ASD, to investigate co-occurring anxiety in this population. The sample was compared to 
a cohort of age- and sex-matched controls. The retrospective study design was utilized to 
collect diagnostic codes from medical records and data collected in previous research 
studies. Retrospective medical record data were compared to an in-person measure of co-
occurring anxiety. These data were compared to medical record data collected on the 
control cohort. Lastly, retrospective data from research studies were used to compare co-
occurring anxiety to factors of employment, and intellectual and adaptive abilities. 
 
Data Analysis  
 Each study in this dissertation uses slightly difference statistical analyses, but the 
overall tests and their assumptions are described here. Descriptive analyses were 
conducted to present sample demographics such as sex, age, intellectual functioning, 
adaptive behavior, employment status, and vocational rehabilitation use. Chi-square tests 
of independence were used to measure the association between variables. This test was 
selected due to the categorical nature of the data used for this dissertation. In addition, the 
data were considered independent, as each item entry contributed to only one cell of the 
contingency table, and the expected frequencies were greater than 5. In cases where cell 
frequencies were less than 5, Fisher’s exact tests were used. Since categorical data are not 
continuous, they cannot be normally distributed, making these analyses nonparametric. 
To match the nonparametric nature of the chi-square test, Spearman’s correlation 




ratio were calculated from contingency tables when the table was 2 x 2. Logistic 
regression was used to predict category membership. This test was chosen due to the data 
being categorical. Multinomial logistic regression was used to predict category 
membership when there were 2 or more categories in the outcome variable (i.e., 
employment status).  
 
Measures 
 No formal or informal measures were used to collect information directly from 
participants in the control sample. Data on prevalence of co-occurring anxiety were based 
on one presence of an ICD-9 billing code corresponding to an anxiety disorder listed in 
Tables 1 and 2.  Existing data of diagnostic billing codes were extracted from the 
Enterprise Data Warehouses of Intermountain Healthcare and University of Utah Health 
Care through linkage with the UPDB.  
In-person or direct contact assessments were performed to obtain information on 
the following: current and past diagnostic status, intellectual functioning, adaptive 
behavior, prevalence of anxiety in the research cohort, and factors of employment. Based 
on family and individual’s preference, assessments were administered in their homes, the 
University of Utah Autism Research Program, or over the phone. Table 3 depicts the 
measures utilized in each of the three studies. 
 
Diagnostic Assessments 
Participants were assessed or reassessed and diagnosed at the time of 




Table 2  
International Classification of Diseases, 9th Revision Codes of Interest and Descriptions  
Label Code 
Anxiety state, unspecified 300.00 
Panic disorder without agoraphobia 300.01 
Generalized anxiety disorder 300.02 
Other anxiety states 300.09 
Hysteria, unspecified 300.10 
Phobic disorders 300.20 
Phobia, unspecified 300.20 
Agoraphobia with panic disorder 300.21 
Agoraphobia without panic disorder 300.22 
Social phobia 300.23 
Other isolated/specific phobias 300.29 
Obsessive-compulsive disorders 300.30 
Posttraumatic stress disorder 309.81 










Table 3      
Summary of Data Collected by Study   
 Study 1    Study 2  Study 3 
 ASD 
Cohort 1 











In-person Measure of 
Anxiety X 
 X -  X 





Adaptive Behavior X  X -  X 
Employment -  - -  X 
 
presentation of ASD symptomatology. Participants were assessed with the Autism 
Diagnostic Observation Schedule (ADOS; Lord et al., 2000) and the Autism Diagnostic 
Interview – Revised (ADI; Lord, Rutter, & LeCouteur, 1994). Three hundred sixty-four 
participants were assessed with the ADOS. Eleven participants were untestable due to 
severe interfering behaviors, blindness, or extremely limited abilities. Four participants 
refused testing and 1 participant was out of the region. In 259 cases, a parent or caregiver 
participated in completing the ADI. Due to the complexity and time requirements in 
administering the ADI and ADOS, the remaining participants (n = 41) were classified 
with ASD using the Social Responsiveness Scale (SRS; Constantino & Gruber, 2005) 
and the Social Communication Questionnaire (SCQ; Rutter, Bailey, & Lord, 2003).  
The SRS is a 65-item, parent-rated questionnaire that assesses the child’s ability to 




0.93-.97; Constantino & Gruber, 2002) assessment consists of five subscales that assess 
autistic fixations/preoccupations, social awareness, capacity for reciprocal social 
responses, social information processing, social motivation, and autistic 
fixations/preoccupations. Higher scores on this assessment indicate greater social skill 
impairments, highly suggestive of an autism spectrum disorder, and imply more severe 
degrees of impairment. While the SRS provides scores for each subscale, the total score 
was used for this study. The SRS was used as a screening tool during the recruitment 
phase and to obtain a quantitative measure of ASD (n = 319).  The Social 
Communication Questionnaire (SCQ) is a parent/caregiver-report screening measure 
consisting of 40-items to assess symptomatology associated with autism spectrum 
disorder. Originally designed as a comparison screening measure for the Autism 
Diagnostic Interview-Revised (ADI-R), the SCQ consists of two measures, Current and 
Lifetime, and provides a cutoff score, which indicates whether an individual is likely to 
have an ASD. For this study, the SCQ was used to screen participants for an ASD (n = 
222) and determine whether or not they required additional testing or if they could be 
considered to have an ASD based on the total score in combination with SRS results. The 
SCQ has research validity (factor analyses α = .26-.73 and item validity α = .53-.64).  
The Autism Diagnostic Interview-Revised (ADI-R) is a comprehensive interview 
that has been proven very useful in evaluating individuals aged 2 years and older for an 
ASD diagnosis. The ADI-R evaluates three functional domains: language and 
communication; reciprocal social interactions; and restricted, repetitive, and stereotyped 
behaviors and interests. A trained clinician administers the ADI-R and interviews a 




of the individual being evaluated. The ADI-R is known to be a valid and reliable 
instrument (reliability α = 0.62-.89; Lord, Rutter, & LeCouteur, 1994).   
 
Anxiety Measures 
The Mini PAS-ADD Clinical Interview is an abbreviated version of the 
Psychiatric Assessment Schedule for Adults with Developmental Disability (PAS-ADD; 
Moss et al., 1998). This psychiatric diagnostic tool contains 86 items and was used to 
assess co-occurring psychiatric disorders. The Mini PAS-ADD was designed for adults 
who have intellectual disability and is comprised of items based on the ICD-9 diagnostic 
algorithms for psychiatric disorders. Traditionally, caregivers are administered this 
semistructured interview by a trained mental health professional. In our study, a 
psychologist, psychology graduate student, or trained nurse administered the interview. 
The Mini PAS-ADD includes seven core symptom domains: depression, expansive mood 
(hypomania/mania), anxiety disorder, obsessive-compulsive disorder (OCD), psychosis, 
and unspecified disorder. The scoring algorithm incorporates the degree of impairment 
that is attributable to symptoms being assessed. Both current (preceding 4 weeks) and 
lifetime presence of symptoms were queried. Several studies have supported the use of 
the Mini PAS-ADD in examining psychiatric disorder prevalence in populations with ID 
(Devine, Taggart, & McLorian, 2009; Holden & Gitlesen 2004; Prosser et al., 1998). 
Sensitivity for the Mini PAS-ADD was found to range between 40-80% (Janssen & 
Maes, 2013) or 100% (Devine, Taggart, & McLorian, 2009). Specificity was found to be 
77% (Devine, Taggart, & McLorian, 2009) or between 71-100% (Janssen & Maes, 




.91; Prosser et al., 1998) have also been observed. One hundred ninety-four participants 
who completed the Mini PAS-ADD linked to the medical billing codes database. In order 
to reflect the historical nature of data represented by the medical billing codes query, the 
Mini PAS-ADD lifetime presence of co-occurring disorders was used. 
 
Diagnostic Codes  
 Diagnostic codes corresponding to anxiety disorders were collected from medical 
billing records to evaluate the presence of co-occurring anxiety. The International 
Classification of Diseases, Ninth Revision (ICD-9) and International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM; Medicore, 1996) were both 
widely used in the two medical systems from which medical record data were collected. 
Codes corresponding to anxiety disorders were collected from the ICD-9 and ICD-9-CM.  
 
Intellectual Ability  
 Participants of the Autism Research Program received standardized and 
individually administered tests to measure intellectual and cognitive abilities. These 
assessment measures differed due to the study in which the participant was ascertained 
and the time point at which the data were collected. The Full Scale standard scores were 
collected from each test to represent an estimate of cognitive abilities. It is known that an 
individual’s Full Scale score from one measure of intellectual ability may not be the same 
on another; however, this information was collected and pooled to capture an estimate of 
participant ability. The following assessment measures were used: Mullen Scales of Early 




n = 68); Leiter International Performance Scale (Leiter-R; Roid & Miller, 1997; n = 5); 
Stanford-Binet Intelligence Scales, Fifth Edition (SB5; Roid, 2003; n = 32); Wechsler 
Intelligence Scale for Children – Third Edition (WISC-III; Wechsler, 1991; n = 11); 
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997; n = 46); 
Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV; Wechsler, 2008; n = 88); 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999; n = 4). When 
possible, the most recently obtained score from a Wechsler measure was used. If a score 
from a Wechsler measure was missing or incomplete, the next most recent and score was 
accepted. These combined scores provide a description of cognitive and intellectual 
abilities across the participants.  
 
Adaptive Behavior   
The Vineland Adaptive Behavior Scales – Survey Edition (VABS; Sparrow, 
Balla, & Cicchetti, 1984) and Vineland Adaptive Behavior Scales, Second Edition 
(Vineland-II; Sparrow, Cicchetti, & Balla, 2005) were used to assess adaptive behavior in 
adulthood. The VABS and VABS-II are individually administered measures for 
individuals aged birth through 90. They are used to assess adaptive behavior in the 
domains of Communication, Daily Living Skills, Socialization, and Motor Skills, and 
provide an overall composite score called the Adaptive Behavior Composite. The VABS 
has been proven reliable (internal consistency reliability score = 0.75 or greater; test-
retest reliability score = 0.88-0.92) and valid. Three hundred four participants had a 
completed VABS (n = 99) or VABS-II (n = 205). Eighty-one participants had a 




recently and provides a more current assessment of adaptive behavior in these 
participants, records with the VABS-II were prioritized.  
 
Employment  
The Adult Outcome Interview (AOI) is an informant-based interview developed 
for this study. It was used to assess participants’ residential situations, work histories, use 
of social services, transportation, experiences with law enforcement, and chronic medical 
or co-occurring psychiatric conditions. One hundred eleven participants had a completed 
AOI. While the AOI provides a great deal of information, only employment information 
was used for this dissertation. Information regarding employment included factors such 
as employment status at the time of data collection, participation in a sheltered workshop 
or day program, number of jobs in lifetime, volunteer positions, and types/length of 
employment positions. Only information that reflected current employment status was 
used for this study.  
 
Study 1 
 The aim of Study 1 was to validate the use of diagnostic billing codes to study the 
psychiatric health status of adults with ASD. Participant information from the University 
of Utah Autism Research Program was linked to data in the UPDB. The UPDB was used 
to match participants to their medical billing codes in order to obtain information on the 
presence of anxiety using surveillance data collected through medical billing codes. 
Surveillance data were then compared to the data collected through the participant’s in-





 From the larger sample of 432 participants with ASD who originated from 
University of Utah Autism Research Program studies, a subsample of participants was 
created. This subsample (Table 4) consisted of 194 participants for whom we had both a 
completed Mini PAS-ADD and diagnostic billing code data.  Eighty-one participants 
were ascertained from the Transition’s Study. Ninety-three were ascertained from the 
Adult Outcome or Adult Follow-up study. Twenty participants participated solely in the 
Genetics study. The age at the time of in-person data collection ranged from 16 to 59 (M 
= 30.48, SD = 9.4) and the age at the time of billing code ascertainment ranged from 22 




 Several procedures were conducted in order to obtain and process diagnostic 
billing code data for analysis. A list of University of Utah Autism Research participants 
was sent to the UPDB to be matched to their records in the database. A document was 
created that listed the University of Utah study identification number and UPDB unique 
identifier for cases and UPDB unique identifiers for controls. The document also 
contained a case identification number that linked cases to their controls. Once the 
participants were matched to the database, UPDB staff matched the participant’s UPDB 
record to medical records in either the UUHSC or IHC databases. A document containing 
identification numbers of participants who matched to a UUHSC record was sent to an 





employee at the IHC data warehouse containing participants who matched to IHC 
records. In addition, a list of diagnostic codes from the International Classification of 
Diseases, Ninth Edition (ICD-9) was sent along with each list of participants.  
The two healthcare systems had slightly different ways of obtaining and providing 
data to me. The UUHSC data warehouse employee first conducted a quality check to 
identify invalid or missing ICD-9 codes. Some codes were invalid due to a misplaced 
Table 4  
Study Demographics 
 N Mean Range SD N (%) 
  Age Male 
Complete Sample 2472 31.14 (18-85) 11.4 2154 (87.1) 
Complete ASD Cohort  432  31.01 (18-85) 11.4 376 (87.0) 
Study 1    
   ASD Cohort 1 194 36.13 (22-64) 9.6 165 (85.1) 
Measures      
   IQ 177 74 (13-140) 32.9 - 
   IQ Missing or Untestable 97 - - - - 
   Mini PAS-ADD-Interview 194 - - - - 
Study 2      
   Control Cohort 2060 31.14 (18-85) 11.4 1795 (87.1) 
   ASD Cohort 2 412 31.14 (18-85) 11.4 359 (87.1) 
Study 3      
   ASD Cohort 3 304 32.20 18-64 10.5 268 (88.2) 
Measures      
   IQ 304 80.81 13-138 31.2 - 
   VABS or VABS-II a 304 53.87 20-116 24.8 - 
   Employment Information 106 - - - - 




decimal, an additional numeral after the decimal, or the codes were missing additional 
numerals that severed as specifiers. The original list of ICD-9 codes was amended so that 
codes matched those in the system. A document with the code, the diagnostic label, and 
larger classification was created. For each participant with a UUHSC record, the UUHSC 
medical informaticist extracted ICD-9 billing codes in the list provided. A document that 
was created containing participant identification numbers, the specific ICD-9 billing 
code, the date of first and last diagnosis, and frequency of diagnosis was provided to the 
me. Some UUHSC data also contained a variable indicating where in the diagnostic list 
the ICD-9 billing code fell.  
In order to analyze the data and compare it to the in-person assessment record, 
indicator variables were created to indicate the presence of each specific anxiety disorder 
(e.g., generalized anxiety, social anxiety, etc.). Indicator variables were also created to 
indicate the overall presence of anxiety. Specifically, three separate indicator variables 
were created to identify case status of anxiety. One variable that indicated any anxiety 
disorder inclusive of obsessive-compulsive disorder (OCD) was labeled “Anxiety/OCD.” 
One variable indicated OCD only, “OCD.” The final variable indicated the presence of 
any anxiety disorder excluding OCD, “Anxiety.” These variables were labeled to indicate 
type of anxiety and that the data were from a UUHSC record.  
The IHC data collection process differed slightly. A list of participants with 
identified IHC medical records, as well as the same list of ICD-9 codes provided to 
UUHSC, was sent to an IHC data warehouse employee. The ICD-9 code list consisted of 
all mental health disorder codes, as well as other medical conditions, to be used in further 




preferred to simplify the extraction process. Codes were grouped by category (e.g., 
depressive disorders, schizophrenia, anxiety state, OCD, social phobia, etc.) and data 
were provided to me already in the form of indicator variables. Variables provided to me 
indicated the presence of categorical mental health disorders and specific anxiety 
disorders. Case status was identified with a “1” or a “0.” To create similar variables to the 
UUHSC data, I created three indicator variables for the overall presence of any anxiety 
disorder (Anxiety/OCD), OCD, or anxiety without OCD (Anxiety). These variables were 
labeled with a descriptor and that the data came from IHC sources.  
Finally, the goal of this study was to increase the robustness of the dataset by 
incorporating data from both healthcare systems. Additional indicator variables were 
created to incorporate data from both systems. Variables indicated the presence of 
individual anxiety diagnoses, any anxiety diagnosis, OCD, and anxiety without OCD. 
These were labeled to indicate data from any medical record.  
A similar process was done for data from the Mini PAS-ADD. The Mini PAS-
ADD consists of numerous interview items aimed at identifying the presence of a 
symptom. Items are grouped into several scales for specific psychiatric conditions. The 
cutoff scores for each scale warrant a diagnosis. Final data were presented as a score for 
each scale; therefore, indicator variables were created to indicate whether or not a 
participant’s score met the cutoff for an anxiety exclusive of OCD, OCD, or anxiety 
inclusive of OCD. These indicator variables were used to compare a participant’s in-







SPSS Version 24 was used to conduct all statistical analyses. Descriptive analyses 
were conducted to present sample demographics such as sex, age, and presence of 
comorbid intellectual disability. The same was done with the Mini PAS-ADD. A chi-
square test of independence was used to investigate the association between co-occurring 
anxiety found in the Mini PAS-ADD and diagnostic billing code data. Agreement of co-
occurring anxiety across records was compared between participants using Spearman’s 
rho. Values of 0.10 were considered to have a small effect, 0.30 were considered a 
medium effect, and 0.50 to have a large effect (Cohen, 1988). Lastly, specificity, 
sensitivity, positive predictive value, and negative predictive values were calculated to 
measure the performance of diagnostic billing codes.  
 
Study 2 
The second study analyzed the prevalence of co-occurring anxiety in adults with 
ASD. Given acceptable validity demonstrated in Study 1, surveillance data were used to 
describe co-occurring anxiety in adults with ASD (N = 412) and the age- and sex-
matched general population controls (N = 2060). The categories of anxiety disorders 
present in adults with ASD were described and compared to that of controls. This study 
will provide the field with more information as to the categories of anxiety and 
prevalence of anxiety seen in adults with ASD. In addition, the presence of anxiety was 







Study 2 consisted of 2472 participants (Table 4). The ASD sample for Study 2 
was a subset of the larger sample. There were 20 participants in the larger ASD sample 
who had inadequate diagnostic billing code data availability for matched control selection 
and were subsequently removed for Study 2. The remaining ASD cohort for Study 2 
consisted of 412 participants. There were 2060 participants in the control cohort. The 
mean age of the entire sample was 31.14 (range = 18-85, SD = 11.4). The cohort was 
87.1% male (n = 2154).  
 
Methods 
 The aim of this study was to compare the prevalence of co-occurring anxiety 
between adults with ASD and adults in a control cohort. Diagnostic code data from both 
healthcare systems were used to conduct these analyses. The indicator variables of 
Anxiety, OCD, and Anxiety/OCD described in the previous section were used to compare 
overall prevalence of the disorder. The data were cleaned and organized in order to 
describe and compare the prevalence of individual diagnostic codes.  
Data from the UUHSC system were presented with ICD-9 diagnostic codes as the 
data. Data from IHC were presented as indicator variables based on the different ICD-9 
codes requested. For example, one variable was labeled “Anxiety_ST_3000” to represent 
the presence of a diagnostic code for anxiety states. The UUHSC data were cleaned and 
organized to match this. I created UUHSC indicator variables for each diagnostic code 
with “1” indicating the presence of the code and “0” indicating the absence of a code 




include data from both sources. The diagnostic code categories for other isolated or 
specific phobia, phobia unspecified, and agoraphobia without panic disorder had very 
small frequencies, with the frequency sometimes being 0 or 1. These diagnostic codes 
categories all indicated the presence of some phobia, so the data were collapsed into one 
larger category to indicate overall phobias.  
 
Data Analysis 
Descriptive analyses were conducted to present sample demographics, frequency 
of co-occurring anxiety, and frequency of anxiety disorder category. Frequencies of 
anxiety variables and anxiety disorders were compared between ASD and control 
participants with chi-square analyses. Fisher’s exact test was used for comparisons when 
a variable had cell size less than 5.  Comparisons were considered statistically significant 
at the 0.05 level. Frequencies of anxiety variables and anxiety disorders were also 
compared between males and females with chi-square analyses. Odds ratios were 
calculated to reflect risk between the larger groups and sexes.  
 
Study 3 
The purpose of Study 3 was to evaluate the association between the presence of 
co-occurring anxiety and factors of adaptive functioning in adults with ASD, specifically 
employment status, and intellectual and adaptive behavior. Association between these 
factors and presence of co-occurring anxiety was explored. A significant association 






 The Study 3 sample consisted of the entire ASD sample (Table 4; N = 304). The 
age of these participants ranged from 18 to 64 (M = 32.20, SD = 10.47). The sample was 
88.2% male. Inclusion criteria for this sample included completed measures of 
intellectual functioning and adaptive behaviors. The average Full Scale IQ was 80.81 
(range = 13-138, SD = 31.19). The VABS and VABS-II were used in this study. The 
average Adaptive Behavior Composite score from the VABS or VABS-II was 53.87 
(range = 20-116, SD = 23.79). One hundred six participants had a completed AOI, which 
provided information on employment.  
 
Methods  
 The sample was determined by the presence of both a completed assessment of 
intellectual functioning and adaptive behavior. These participants were identified from 
the larger same of 432 participants. Indicator variables were created to indicate the 
presence of co-occurring anxiety. Data from both diagnostic billing codes and the Mini 
PAS-ADD were used to indicate case status. Data from the Mini PAS-ADD were 
prioritized due to the more comprehensive nature of interview. Diagnostic code data were 
used when a Mini PAS-ADD was missing, as was the case for 110 participants. 
 
Data Analysis 
Descriptive analyses were conducted to present factors of adaptive functioning. 
Chi-square analyses were conducted to explore the relationship between prevalence of 




than 0.05 were considered statistically significant. Effect sizes were measured by odds 
ratios (OR) and 95% confidence intervals (95% CI). Frequencies of anxiety were 














 Data were collected on 432 participants with ASD and 2060 control participants. 
The research questions were answered through three different studies, all using different 
subsamples. Demographics for the full sample, as well as subsamples, are displayed in 
Table 4.  
The sample for Study 1 consisted of 194 participants who had both diagnostic 
code data from medical billing records and a complete Mini PAS-ADD. Lifetime 
diagnosis from the Mini PAS-ADD was used to represent case status for co-occurring 
anxiety. The age ranged from 22-64, M = 36.16, SD = 9.59, and there were 165 male 
participants (85.1%). Intellectual quotients were available for 177 participants. The 
average IQ was 74 (range=13-140, SD = 32.91). Sixteen participants were untestable but 
estimated to have severely limited intellectual and verbal abilities. Intellectual quotients 
could not be obtained on 1 participant because the family declined consent to in-person 
assessments but agreed to complete questionnaires that could be completed over the 
phone. One hundred forty-two participants (73.2%) were White and the race of 52 
participants was unknown.  
Sample 2 consisted of a subsample of participants from the larger ASD cohort and 
a control cohort matched based on age, sex, and duration of time living in Utah. There 




mean, range, and standard deviation for age was the same for both cohorts, M = 31.14, 
18-85, SD = 11.5. Eighty-seven percent of samples were male, with 1795 male 
participants in the control cohort and 359 male participants in the ASD cohort. Diagnostic 
code data we available for each participant and no other measures were used with these 
samples.  
The sample for Study 3 consisted for 304 participants from the larger ASD cohort. 
This sample was created based on participants with a completed record of intellectual and 
adaptive behavior. The mean age was 32.30 (18-64, SD = 10.47) and 88.2% (n = 268) 
participants were male. Diagnostic code data were available for all participants. All 304 
participants had an estimated intellectual quotient. The mean IQ was 32.30 (13-138, SD = 
31.19). All participants in this sample have a completed record of adaptive behavior 
using either the VABS or VABS=II. Data from the VABS were only used when the 
VABS-II was missing, resulting in the use of data from 209 VABS-II and 99 VABS. The 
Adaptive Behavior Composite was used to represent overall adaptive behavior abilities. 
The average Adaptive Behavior Composite standard score was 55.87, ranging from 20-
116, SD = 24.79. Information on employment factors, use of vocational rehabilitation 
services and employment status, was collected on 106 participants.  
 
Research Question #1 
How reliable is the use of diagnostic billing codes from electronic healthcare records for 
describing co-occurring anxiety in adults with ASD? 
Diagnostic codes are used to present the prevalence of medical and psychiatric 




investigate and present the prevalence of conditions in participants with ASD. These data 
provide an efficient and cost-reductive way to collect data, but the reliability and validity 
of these data has yet to be studied. In order to investigate this concept, through the sample 
and procedures of Study 1, diagnostic code data were compared to data from an in-person 
semistructured interview. Results from these analyses are listed in Table 5 and described 
below.  
 
Association Between Diagnostic Codes and Mini PAS-ADD 
Chi-square tests were used to test for association between diagnostic code case 
status and Mini PAS-ADD lifetime diagnostic case status for Anxiety, OCD, and 
Anxiety/OCD. Significant associations were found between diagnostic code case status 
and the Mini PAS-ADD case status for Anxiety, c2 (1, N = 194) = 4.5, p = .035; OCD, c2 
(1, N = 194) = 14.6, p < .001; and Anxiety/OCD, c2 (1, N = 194) = 3.91, p = .048.  
While associations were found between diagnostic code case status and Mini PAS-ADD 
case status, I sought to determine the relationship between these variables. Spearman’s 
correlation coefficient was used to explore this relationship. The Spearman’s correlation 
coefficient for Anxiety/OCD met significance (p = .048) and yielded a weak correlation 
(rs = .14). Spearman’s correlation coefficient for Anxiety was statistically significant 
indicating a significant, yet weak correlation (p = .035; rs = .15). Lastly, Spearman’s 
correlation coefficient for OCD had the strongest significance and a moderate correlation 
(p < .001; rs = .27). The correlation for OCD held the strongest significance and had the 























































































































































































































































































































































































Validity of Diagnostic Billing Codes  
The first aim of Study 1 was to measure the association and relationship between 
the diagnostic code case status and Mini PAS-ADD case status. If associations were 
found, as they were, the second aim of Study 1 was to measure the validity and evaluate 
strengths and weaknesses of using diagnostic codes to present the prevalence of co-
occurring anxiety. More specifically, I was interested in whether or not diagnostic codes 
were capturing co-occurring anxiety similarly to the capture of an in-person 
semistructured assessment. Specificity and sensitivity were calculated to reflect the 
validity of using diagnostic codes to evaluate the presence of co-occurring anxiety 
disorders in adults with ASD (Table 5). The Lifetime diagnostic status from the Mini 
PAS-ADD was used as the standard for all comparisons due to its established metrics. 
Diagnostic code case status was compared to Mini PAS-ADD case status for all 
variables: Anxiety, OCD, and Anxiety/OCD.  
The sensitivity estimate for Anxiety was 54.9%. This indicates that diagnostic 
code data detected about 55% of the participants with an anxiety disorder, as determined 
by the lifetime diagnostic status from the Mini PAS-ADD. This estimate suggests that 
diagnostic codes detected only half of the participants with anxiety. The specificity 
estimate was slightly higher at 60.5%. Of the participants who had a negative Mini PAS-
ADD case status for anxiety, 60% also had a negative case status for anxiety from 
diagnostic codes. These estimates suggest that diagnostic codes capture just over half of 
the participants with anxiety and capture slightly more participants without an anxiety 
disorder.  




with a specificity estimate of 87.8%. The sensitivity was low, 35.2%, meaning that 
diagnostic codes detected 35% of participants with OCD. This low sensitivity estimate 
corresponded to a high specificity estimate, as 88% of the participants without OCD had 
no diagnostic codes for OCD. The high specificity estimate suggests that diagnostic 
codes are highly specific in identifying participants without OCD.  
Lastly, when Anxiety and OCD were combined into the variable Anxiety/OCD, 
there was an interesting switch. The sensitivity estimate, 59.5%, increased and the 
specificity estimate decreased, 55.6%. When the variables were combined, diagnostic 
codes were more sensitive to detecting the presence of any anxiety disorder. This value 
was still rather low and a moderate proportion of the sample with anxiety was undetected; 
however, the value was approaching a more acceptable level. When combined, diagnostic 
codes for anxiety are more sensitive and capture more participants with the disorder. The 
lower specificity estimate suggests that when the variables are combined, diagnostic 
codes are less specific in detecting an anxiety disorder.  
 
Research Question #2 
What are the strengths and weaknesses of billing data for describing co-occurring 
conditions in individuals with ASD?  
This question is largely answered in the discussion section, but some results 
reflecting investigation of this question are presented here. Study 1 procedures were used 
to calculate positive predictive values (PPV) and negative predictive values (NPV) to 
reflect some strengths and weaknesses of using billing data to describe co-occurring 




(presence of a billing code) for anxiety who actually have anxiety based on the semi-
structured Mini PAS-ADD. The NPV is the proportion of participants with a negative 
diagnostic case status (absence of a billing code) who truly do not have the disorder.  
The PPV for anxiety was 66.0%, indicating that 66% of the participants with a 
positive diagnostic billing code for anxiety was correctly identified. The PPV for OCD 
implied that 62.5% of the participants with a positive diagnostic billing code for OCD 
actually had OCD. The highest PPV was for the combined variable of Anxiety/OCD. The 
PPV estimated that 73.6% of the participants with Anxiety/OCD truly had at least one of 
these disorders. The higher PPV estimate suggests what when the definition of anxiety is 
expanded to include a broader range of diagnoses, the predictive ability of diagnostic 
codes as a single entity increases.  
Negative predictive values for Anxiety and Anxiety/OCD were 49.0% and 39.8%, 
respectively. The negative predictive value for OCD was much higher at 70.1%. NPVs 
suggest that when a participant was absent of a diagnostic code for OCD, they had a 70% 
change of not having the disorder. Alternatively, when a participant was lacking a 
diagnostic billing code for Anxiety or Anxiety/OCD, they were only 49.0% and 39.8% 
likely to truly be absent of an anxiety disorder.  
 
Research Question #3 
What is the prevalence of co-occurring anxiety in adults with ASD? 
Study 2 aimed to present the prevalence of co-occurring anxiety in adults with 
ASD. The sample used to investigate the prevalence of co-occurring anxiety consisted of 




separately to present prevalence. These data were also combined to present prevalence 
when either method was used. Diagnostic code data were used to report prevalence of 
specific anxiety disorders. These results are presented in Table 6.   
 
Co-occurring Anxiety in Adults With ASD 
 The Mini PAS-ADD, a semistructured diagnostic interview, was used to present 
lifetime prevalence of co-occurring anxiety disorders. In the sample of 412 participants, 
194 had a completed Mini PAS-ADD. Fifty-eight percent of the participants (n =113) had 
co-occurring Anxiety. Thirty-six percent of the sample (n = 71) met criteria for OCD. 
Lastly, 67.3% of the participants (n =131) had either Anxiety and/or OCD.   
Diagnostic code data were also used to analyze and present these findings (n = 412). 
Forty-six percent of the sample (n =191) had a diagnostic billing code representing an 
anxiety disorder. Fifty percent (n =206) of the sample had a positive case status for 
Anxiety/OCD. Seventy-three participants (17.7%) had diagnostic codes specific to OCD.  
Mini PAS-ADD data and diagnostic code data were combined to present the 
prevalence of co-occurring anxiety when both data sources were considered. All 412 
participants with ASD were included for this estimate. The prevalence of co-occurring 
Anxiety was 57.3% (n = 236). Prevalence for co-occurring OCD was 28.4% (n = 117). 
Finally, 61.7% of the sample (n = 254) had Anxiety/OCD. 
In addition to reporting the overall prevalence of anxiety in adults with ASD, the 
aim of Study 2 was to investigate the presentation of anxiety disorders in this population. 
For example, it was questioned as to whether or not individuals with ASD more 






























































   




































































































































































































































































































































































































































































































   
   




































































































































































unspecified, was the most common co-occurring diagnosis (n = 179, 43.4%). In fact, 
93.7% of the participants with a diagnostic case status for anxiety had a diagnostic code 
for anxiety state, unspecified. Generalized anxiety disorder (n = 81, 19.7%) was the next 
most common co-occurring anxiety diagnosis. The remaining diagnoses were far less 
frequent, with proportions at 3.4% or less of the sample (n < 14).   
 
Research Question #4 
How does the prevalence and types of anxiety disorders experienced by adults with ASD 
compare to the general population? 
Study 2 procedures were used to investigate this question. The prevalence of 
overall anxiety disorders and specific disorders was compared between adults with ASD 
and a control cohort. Diagnostic code data were used to present prevalence. The control 
cohort was considered the general population, but I was aware that the control cohort is 
largely specific to the Utah region. The results investigating this question are described 
below and in Table 6.  
 
Prevalence Comparisons Between Adults With ASD and Controls  
 The prevalence of co-occurring anxiety in adults with ASD was compared to the 
prevalence of anxiety in an age- and sex-matched control cohort (Table 6). Chi-square 
associations were used to compare the frequency of co-occurring anxiety in adults with 
ASD with the frequency of anxiety in a control cohort. Significant associations were 
found for all three categories: Anxiety, c2 (1, N = 2472) = 284.677, p < .001, OCD, c2 (1, 




The proportion of ASD participants with a case status of Anxiety (46.4%) was 
significantly higher than the proportion of control participants with a case status of 
Anxiety (11.7%). The proportion of adults with ASD with a case status of OCD (17.7%) 
was significantly higher than that of the proportion of control participants with OCD 
(8%). In addition, the proportion of Anxiety/OCD was significantly higher in the ASD 
cohort (50.0%) than the control cohort (13.4%) 
Similar to the ASD cohort, the most common diagnostic code for the control 
cohort was Anxiety State, Unspecified. The remaining disorders had proportions less than 
3.1% (n < 64). Chi-square tests of association were used to test for associations in the 
proportion of specific anxiety disorders between the two cohorts. Significant associations 
were found for the following: anxiety state, unspecified, c2 (1, N = 2472) = 273.703, p < 
.001; generalized anxiety disorder, c2 (1, N = 2472) = 170.382, p < .001; panic disorder 
without agoraphobia, c2 (1, N = 2472) = 11.311, p = .001. Fisher’s exact tests were used 
when a cell size was less than 5, as was the case for the following categories, all with 
significant associations: social phobia, c2 (1, N = 2472) = 44.818, p < .001; posttraumatic 
stress disorder, c2 (1, N = 2472) = 19.388, p < .001; panic disorder with agoraphobia, c2 
(1, N = 2472) = 20.563; overanxious disorder, c2 (1, N = 2472) = 24.097, p < .001; other 
phobia, c2 (1, N = 2472) = 8.032, p = .015. The proportion of ASD participants with these 
anxiety disorders was significantly higher than that of control participants. Forty-three 
percent of the ASD cohort (n = 179) had a diagnostic code for anxiety state, unspecified 
compared to 10.6% (n = 219) of the control cohort. Three percent of the control cohort (n 
= 64) had a diagnostic code for generalized anxiety disorder, compared to 19% of the 




significant, as determined by Fisher’s exact tests: other anxiety states, c2 (1, N = 2472) = 
3.086, p = .095, and hysteria, unspecified, c2 (1, N = 2472) = 5.002, p = .167. It should be 
noted that while statistics were run to evaluate the association between the cohorts, some 
diagnostic codes had very small frequencies. In fact, the frequencies for some diagnostic 
codes were 0 or 1. In both the ASD and Control samples, the most common diagnostic 
codes were anxiety state, unspecified generalized anxiety disorder, and panic disorder 
without agoraphobia. The remaining diagnostic code categories had frequencies less than 
15.  
 Odds ratios and confidence intervals were also calculated to reflect risk between 
the two cohorts. Adults with ASD were 6.44 times more likely to have anxiety than 
adults in the control cohort. Adults with ASD were 27.51 times more likely to have OCD 
than adults in the control cohort. Risk for specific co-occurring anxiety disorders ranged 
from 2.88 to 30.43. Overall, adults with ASD were much more likely to have a co-
occurring anxiety disorder than adults in the control cohort.  
 
Prevalence of Anxiety Compared to National Prevalence  
The national prevalence of any or select anxiety disorders was visually compared 
to rates of anxiety in both the ASD cohort and the control cohort (Table 6). Upon visual 
analysis, rates of co-occurring anxiety in adults with ASD appear to be higher than those 
found in the general population. Rates of anxiety in the control cohort appear to be lower 
than proportions or the national sample. The national prevalence rates used for 
comparison were derived from a sample of adults ages 18-64. There were slightly more 




contained a narrower age range and consisted of far more females than in the samples 
used for this study. It is possible that if the demographics in the control cohort used for 
this dissertation were more similar to the demographics of the sample used for the 
national prevalence rates, the prevalence rates may be more consistent.  In addition, 
prevalence rates for the national sample were derived from phone interviews surveying 
co-occurring disorders, which differed from the diagnostic code data used to present 
prevalence in our control cohort.   
 
Prevalence of Anxiety Compared Between Sexes  
In addition to comparing the prevalence of anxiety between the ASD and control 
cohort, the prevalence of anxiety was compared between males and females (Table 7). 
Comparisons were made between males and females in the ASD cohort and males and  
females in the control cohort. Chi-square tests were used to compare the frequency of 
anxiety found in women with the frequency of anxiety found in men, with significance at 
the .05 level. Fisher’s exact tests were used when the cell size was less than 5.  
For the ASD cohort, chi-square tests of association indicated significant 
associations for the major anxiety variables when the frequency of co-occurring anxiety 
was compared between sexes: Anxiety, c2 (1, N = 412) = 6.187, p = 0.013; OCD, c2 (1, N 
= 412) = 4.673, p = 0.031; Anxiety/OCD, c2 (1, N = 412) = 7.817, p = 0.005. For each 
variable, the proportion of females with anxiety was greater than the proportion of males 
with anxiety. Sixty-two percent of females had anxiety (n = 33), while 44.0% of males 
had anxiety (n = 158). In those with OCD, the proportion of females with OCD (n = 15, 



























































































































































































































































































































































































































































































   











































































































































































percent of females had Anxiety/OCD (n = 33) compared to 47.4% of males (n = 158). 
There were no statistical associations found between males and females with ASD when 
the frequency of individual diagnostic codes was compared between sexes.  
In the control cohort, there was a significant association found between females 
and males with Anxiety/OCD, c2 (1, N = 2060) = 4.807, p = .028. The proportion of 
females with Anxiety/OCD (n = 47, 17.7%) was higher than the proportion of males (n = 
230, 12.8%).  No statistical associations were found between sexes for Anxiety or OCD, 
c2 (1, N = 2060) = 2.587, p = .108, c2 (1, N = 2060) = 2.119, p = .146. Chi-square tests 
indicated a statistical association between males and females for the diagnostic code of 
unspecified anxiety state, c2 (1, N = 2060) = 4.402, p = 0.036, as there was a higher 
proportion of anxiety in females (n = 38, 14.3%) than males (n = 181, 10.1%). 
 
Research Question #5 
What is the association between the presence of co-occurring anxiety in adults with ASD 
and their adaptive functioning? 
 Study 3 was the final study for this dissertation and used to evaluate this question. 
Study 3 aimed to evaluate the association between co-occurring anxiety and factors of 
adaptive functioning in adults with ASD, as well as factors of employment. I was 
interested in whether or not the proportion of co-occurring anxiety differed between 
levels of intellectual or adaptive behavior. In addition, I was interested in the association 
between co-occurring anxiety and factors of employment. The sample used for these 
evaluations consisted of 304 adults with ASD. This sample included only participants 




Wilcoxon signed-ranks tests were used to examine whether or not the ASD cohort used in 
comparison to controls differed from the larger ASD cohort in sex or age. The Wilcoxon 
S-R tests indicated that the samples did not differ in either sex, z = -.302, p = 0.763, or 
age, z = -.023, p = 0.982. The presence of co-occurring anxiety was derived from both 
diagnostic billing codes (n = 110) and the Mini PAS-ADD (n = 194).  
 
Co-occurring Anxiety and Intellectual Functioning 
Chi-square tests of association were used to compare the frequency of co-
occurring anxiety disorders in three levels of intellectual functioning: Normal ≥ 70, Mild 
intellectual disability = 50-69, Severe intellectual disability < 50 or untestable (Table 8). 
Significant associations were found for Anxiety and Anxiety/ODD when the frequency of 
co-occurring anxiety was compared with intellectual functioning: Anxiety, c2 (2, N = 
304) = 6.54, p = 0.038, and Anxiety/OCD, c2 (2, N = 304) = 9.97, p = 0.007. No 
significant association was found when the frequency of co-occurring OCD was 
compared to the frequency of intellectual functioning categories, c2 (2, N = 304) = 4.724, 
p = 0.094. Among those with anxiety, the proportion of participants with severe ID or 
untestable intellectual functioning was 31.0% (n = 53). This proportion was higher than 
the 17.9% (n = 21) of participants without anxiety who also had severe ID. A similar 
association was found for participants with Anxiety/OCD, as the proportion of 
participants with Anxiety/OCD and severe ID was 31.4% (n = 64) and the proportion of 
participants without Anxiety/OCD and severe ID was 15.0% (n = 15). Among those  










































   
   
   






   
   
   





   
   






































































































































































































































   
   
 
   

































































































































































































































   


































































































































































































































































































































   
   
   
   
   
   
   




















































































































































































68.4% (n = 80), which is was higher than the proportion of participants with Anxiety and 
normal intellectual functioning (56.1%, n =105). The same was found in participants with 
or without Anxiety/OCD. The proportion of participants without Anxiety/OCD and 
normal intellectual functioning (n = 72, 72%) was higher than the proportion of 
participants with Anxiety/OCD and normal intellectual functioning (n = 113, 55.4%). 
Logistic regression was used to predict case status for co-occurring anxiety based 
on category of intellectual functioning. Normal intellectual functioning was used as the 
reference variable and was compared to mild ID and severe ID/untestable. For the 
variables of Anxiety and Anxiety/OCD, having severe ID or untestable intellectual 
abilities significantly predicted co-occurring anxiety, b = .74, p = .012, b = 1.00, p = .002. 
Participants with severe ID or untestable intellectual functioning were 2.1 times more 
likely to have Anxiety and 2.7 times more likely to have Anxiety/OCD. Severe ID or 
untestable abilities did not significantly predict OCD, b = .53, p = .062. The category of 
Mild ID did not significantly predict and of the anxiety variables, Anxiety, b = .13, p = 
.707; OCD, b = .56, p = .122; Anxiety/OCD, b = .28, p = .449.  
 
Co-occurring Anxiety and Adaptive Behavior 
I was curious about the association of co-occurring anxiety and level of adaptive 
behavior. Chi-square tests of association were used for this analysis (Table 8). Adaptive 
behavior was measured by the VABS and VABS-II using the Adaptive Behavior 
Composite and the Communication, Daily Living, and Social scales. Standard scores 
were collapsed into three levels: normal ≥ 70, mild = 50-69, and severe < 50.  




adaptive behavior, significant associations were found for the Adaptive Behavior 
Composite, c2 (2, N = 304) = 10.835, p = 0.004; Communication, c2 (2, N = 304) = 
10.773, p = 0.005; Daily Living, c2 (2, N = 304) = 6.221, p = 0.045; and Social, c2 (2, N = 
304) = 9.433, p = 0.009. For all comparisons between categories of adaptive behavior, 
participants with Anxiety were seen to have higher proportions of severe ID: Adaptive 
Behavior Composite, n = 90, 48.1%; Communication, n = 99, 52.9%; Daily Living, n = 
78, 41.7%, and Social, n = 92, 49.2%. Of participants without anxiety, the proportion of 
participants with severe adaptive behavior was less: Adaptive Behavior Composite, n = 
34, 29.1%; Communication, n = 41, 35.0%; Daily Living, n = 35, 29.9%; Social, n = 37, 
31.6%. Similar to intellectual functioning, in participants without anxiety, the proportion 
of participants with normal adaptive behavior abilities was higher (Adaptive Behavior 
Composite, n = 41, 35.0%; Communication, n = 55, 47.0%), Daily Living (n = 31, 
26.5%), and Social (n = 43, 36.8%) than the proportion of normal adaptive behavior in 
participants without Anxiety (Adaptive Behavior Composite, n = 48, 25.7%; 
Communication, n = 56, 29.9%), Daily Living (n = 52, 27.8%), and Social (n = 47, 
25.1%). 
When OCD was compared to factors of adaptive behavior, significant 
associations were found between sales of Adaptive Behavior Composite, c2 (2, N = 304) 
= 19.164, p < 0.001; Communication, c2 (2, N = 304) = 14.343, p = 0.001; and Social, c2 
(2, N = 304) = 24.160, p = 0.009. There was not a significant association found for the 
Daily Living scale, c2 (2, N = 304) = 4.830, p = 0.089. The proportions followed the same 
trends as when anxiety was compared to adaptive behavior. Participants with OCD 




n = 57, 58.2%; Daily Living (n = 45, 45.9%), and Social (n = 61, 62.2%), where 
participants without OCD experienced lower proportions of having severe ID (Adaptive 
Behavior Composite, n = 67, 32.5%; Daily Living (n = 68, 33.0%), and Social (n = 68, 
33.0%).  
 Significant associations were found when each adaptive behavior variable was 
compared to Anxiety/OCD: Adaptive Behavior Composite, c2 (2, N = 304) = 15.467, p < 
.001; Communication, c2 (2, N = 304) = 14.965, p = 0.001; Daily Living, c2 (2, N = 304) 
= 8.754, p = 0.013; and Social, c2 (2, N = 304) = 11.650, p = 0.003. The proportions were 
similar to those found in the other anxiety categories, with a higher proportion of 
participants with severe ID found in participants with Anxiety/OCD (Adaptive Behavior 
Composite, n = 99, 48.5%; Communication, n = 109, 53.4%), Daily Living (n = 86, 
42.2%), and Social (n = 100, 49.0%) than in participants without Anxiety/OCD 
(Adaptive Behavior Composite, n = 25, 25.0%; Communication, n = 31, 31.0%), Daily 
Living (n = 27, 27.0%), and Social (n = 29, 29.0%) Likewise, a higher proportion of 
participants with normal adaptive behavior was found in participants without 
Anxiety/OCD (Adaptive Behavior Composite, n = 38, 38.0%; Communication, n = 50, 
50.0%), Daily Living (n = 27, 27.0%), and Social (n = 39, 39.0%) than in participants 
with Anxiety/OCD (Adaptive Behavior Composite, n = 51, 25.0%; Communication, n = 
61, 29.9%), Daily Living (n = 56, 27.5%), and Social (n = 51, 25.0%).  
Logistic regression was used to predict whether a participant had anxiety given 
their normal, mild, or severe adaptive behavior abilities (Table 9, Table 10, Table 11). 
The category for normal adaptive behavior was compared to the categories of mild and 




Table 9  
Results of logistic regression: intellectual functioning and adaptive behavior as 
predictor of anxiety 
 Anxiety 
 B (S.E.) Sig Exp(B) 95% CI 
Intellectual Functioning a     
   Mild ID (50-69) .13 (.36) .707 1.14 .57-2.29 
   Severe ID or Untestable (<50) .74 (.30) .012 2.10 1.18-3.75 
Adaptive Behavior Composite a     
   Mild (50-69) -.00 (.30) .991 1.00 .56-1.79 
   Severe (<50) .82 (.29) .005 2.36 1.27-4.01 
Communication a     
   Mild (50-69) .40 (.34) .234 1.50 .77-2.81 
   Severe (<50) .86 (.27) .001 2.37 1.41-3.99 
Daily Living a     
   Mild (50-69) -.41 (30) .173 .67 .37-1.19 
   Severe (<50) .28 (.31) .351 1.33 .73-2.41 
Social a     
   Mild (50-69) .17 (.30) .573 1.19 .65-2.15 
   Severe (<50) .82 (.29) .004 2.28 1.30-3.99 

















Results of logistic regression: intellectual functioning and adaptive behavior as 
predictor of OCD 
  OCD 
  B (S.E.) Sig Exp(B) 95% CI 
Intellectual Functioning a      
   Mild ID (50-69)  .56 (3.62)  .122 1.75 .86-3.56 
   Severe ID or Untestable (<50)  .53 (.28) .062 1.70 .97-2.96 
Adaptive Behavior Composite a      
   Mild (50-69)  .42 (.36) .264 1.52 .75-3.07 
   Severe (<50)  1.28 (.32) .000 3.60 1.91-6.80 
Communication a      
   Mild (50-69)  .41 (.38) .284 1.51 .71-3.21 
   Severe (<50)  1.05 (.29) .000 2.87 1.63-5.06 
Daily Living a      
   Mild (50-69)  -.10 (.33) .752 .90 .48-1.71 
   Severe (<50)  .49 (.31) .115 1.63 .89-2.98 
Social a      
   Mild (50-69)  -.41 (.38) .273 .66 .32-1.38 
   Severe (<50)  1.02 (.30) .001 2.77 1.53-5.12 














Table 11   
Results of logistic regression: intellectual functioning and adaptive behavior as predictor 
of Anxiety/OCD 
  Anxiety/OCD 
  B (S.E.) Sig Exp(B) 95% CI 
Intellectual Functioning a      
   Mild ID (50-69)  .28 (.37) .449 1.32 .64-2.73 
   Severe ID or Untestable (<50)  1.00 (.324 .002 2.72 1.44-5.13 
Adaptive Behavior Composite a      
   Mild (50-69)  .08 (.30) .782 1.09 .60-1.97 
   Severe (<50)  1.08 (.31) .000 2.95 1.61-5.42 
Communication a      
   Mild (50-69)  .38 (.34) .266 1.47 .75-2.88 
   Severe (<50)  1.06 (.28) .000 2.88 1.67-4.98 
Daily Living a      
   Mild (50-69)  -.43 (.31) .157 .65 .36-1.18 
   Severe (<50)  .43 (.32) .183 1.54 .82-2.89 
Social a      
   Mild (50-69)  .01 (.30) .972 1.01 .56-1.84 
   Severe (<50)  .52 (.28) .060 1.68 .98-2.89 
a Normal (≥70) = reference  
 
and Communication scale significantly predicted Anxiety (b = .82, p = .005; b = .86, p = 
.001), OCD (b = 1.28, p < .001; b = .1.05, p < .001) and Anxiety/OCD (b = 1.08, p < 
.001; b = 1.06, p < .001). Mild adaptive behavior for the Adaptive Behavior Composite, 
Communication, or Social scales did not significantly predict any anxiety variable. 
Severe adaptive behavior on the Social scale significantly predicted Anxiety, b = .82, p = 
.004, and OCD, b = 1.02, p = .001, but not Anxiety/OCD, b = .52, p = .060. Neither 
category of adaptive behavior on the Daily Living scale predicted Anxiety, OCD, or 
Anxiety/OCD. Adults with ASD were 1.33-.360 times more likely to have anxiety or 




Co-occurring Anxiety and Employment Status  
The association between anxiety and factors of employment was explored to 
reflect any potential impact anxiety could have on one’s ability to gain employment. 
Factors of employment included employment status and whether or not a participant had 
accessed vocational rehabilitation services. Employment status was divided into three 
categories reflecting ones ability to be independently employed (Independent); maintain 
employment in a supported environment, such as with a job coach or within a sheltered 
workshop (Supported); or be unemployed (Unemployed), which also included 
participants who participated in a day program, reflecting their inability to supply 
income. In addition, multinomial logistic regressions were used to evaluate whether the 
presence of anxiety predicted participant case status for employment. Independent 
employment was used as the reference variable and compared to the other employment 
categories. The results of these analyses are presented in Table 12. 
Chi-square tests of association were used to compare presence of anxiety to 
employment status. The associations were found to be significant for all anxiety 
variables: Anxiety, c2 (2, N = 106) = 8.585, p = .017; OCD, c2 (2, N = 106) = 14.676, p = 
.001; Anxiety/OCD, c2 (2, N = 106) = 12.789, p = .002). Of those with anxiety, the 
proportion of participants who were unemployed (n = 14, 19.7%) was higher than the 
proportion of participants without anxiety and unemployed (n = 6, 17.1%). Of 
participants without anxiety, the proportion of participants who were independently 
employed (Anxiety, n = 15, 55.6%; OCD, n = 24, 88.9%; Anxiety/OCD, n = 14, 51.9%) 
was higher than the proportion of participants with anxiety who were independently 








While the proportion of participants who had a co-occurring anxiety disorder and were 
independently employed was less than the proportion of participants without an anxiety 
disorder who were independently employed, these proportions only differed by a few 
percentage points. Within participants with Anxiety or Anxiety/OCD, the proportion of 
participants who were unemployed (Anxiety, n = 14, 70.0%; Anxiety/OCD, n = 15, 75%) 
was higher than that of participants without Anxiety or Anxiety/OCD who were 
unemployed (Anxiety, n = 6, 30.0%; Anxiety/OCD, n = 5, 25.0%). The difference 
between these proportions was much larger.  Interestingly, of the number of participants  
who had OCD and were unemployed (n = 10, 50%) was the same as the number of 
participants who were absent of OCD and unemployed (n = 10, 50%). This sample of 
participants used for this analysis also had a far larger proportion of OCD (57%) than in 
the larger ASD cohort (28%).  
Multinomial logistic regression analyses indicated that having OCD significantly 
predicted whether a participant was unemployed or in supported employment when 
compared to those who were independently employed. In those with Anxiety or 
Anxiety/OCD, a positive case status for either variable predicted whether the participant 
was in supported employment or independently employed. Participants who were in 
supported employment were more likely to have anxiety, where participants who were 
independently employed were less likely to have anxiety.  
 Chi-square tests of associations were used to compare the use of vocational 
rehabilitation and anxiety variables, specifically whether or not the participant had 
accessed vocational rehabilitation services. A significant association was found for a 




5.100, p = .024, but no other anxiety variables: Anxiety, c2 (1, N = 106) = 1.805, p = 
.179; Anxiety/OCD, c2 (1, N = 106) = 4.439, p = .067. The proportion of participants 
without OCD who had used vocational rehabilitation (n = 14, 23.0%) was larger than the 
proportion of participants with OCD who had used services (n = 3, 6.7%). The proportion 
of participants without OCD who had not used vocational rehabilitation services (n = 47, 










General Discussion  
 Autism spectrum disorder affects an immense amount of individuals around the 
world. As diagnostic tools have improved, more and more individuals across the lifespan 
are being identified as having the disorder. The majority of research has been conducted 
on infants, children, and adolescents, but researchers are focusing efforts to investigate 
ASD in adulthood, particularly when it comes to outcomes, needs, and areas of strength 
(Baker, 2013). The current literature base shows that adults with ASD have worsened 
outcomes when compared to both their typically developing peers and adults with other 
developmental disabilities (Bakken et al., 2010; Gillot & Standen, 2007). This is even 
true when individuals with ASD have normal intellectual capabilities (Farley et al., 
2009). Adults with ASD tend to have limited employment opportunities and outcomes. 
They are less likely to obtain higher education degrees, have fewer social and romantic 
relationships, have difficulty living independently, and have higher rates of co-occurring 
medical and psychiatric conditions (Buck et al., 2014; Farley et al., 2009; Howlin, 2000; 
Jones et al., 2015; Roux, Shattuck, Rast, Rava, & Anderson, 2015; Wei, Wagner, 
Hudson, Yu, & Shattuck, 2015). Given these factors, research on outcomes in adults with 
ASD is imperative to improving the lives of these individuals, determining service needs, 
and developing interventions or assistance programs.  




experience co-occurring psychiatric conditions, such as depression, anxiety, and attention 
deficit hyperactivity disorder (de Bruin, Ferdinand, Meester, de Nijs, & Verheij, 2007; 
Buck et al., 2014; Howlin, 2000; Roy, Prox-Vagedes, Ohlmeier, & Dillo, 2015). It is well 
known that a single psychiatric condition can impact one’s ability to complete everyday 
tasks and live independently. Research suggests that when an individual experiences co-
occurring conditions, it can further impact their life outcomes (Mojtabai et al., 2015a; 
Mojtabai et al., 2015b). This is likely true when applied to adults with ASD, further 
indicating a need to put forth efforts to research this area (Vannucchi et al., 2014).  
While current literature presents the prevalence of co-occurring psychiatric 
conditions in this population, the estimates widely vary between studies. Studies present 
proportions of co-occurring psychiatric conditions that range from 29 to 70% (de Bruin at 
al., 2007). These studies typically vary in the method of measuring co-occurring 
conditions, with some using screeners (Gotham, Brunwasser, & Lord, 2015) and others 
using in-depth interviews (Hofvander et al., 2009). These studies also widely vary in 
sample size and demographics, with the samples typically being rather small and 
restricted. Overall, researchers are calling for a better understanding of the prevalence 
and presentation of co-occurring psychiatric conditions in this population.   
The current literature base is lacking studies with robust sample sizes. So far, only 
one study has presented co-occurring diagnoses in a sample larger than 400 (Croen et al., 
2015). Croen et al. (2015) used diagnostic codes from medical billing records to present 
the prevalence of co-occurring medical and psychiatric conditions in a sample of over 
1,000 individuals. Diagnostic codes are used in other areas of medical research to present 




affordable and efficient way to present prevalence estimates on a large number of 
individuals, given that these data are already collected and do not require additional in-
person assessments or ascertainment. One limitation to the use of diagnostic billing codes 
is that the data are limited to when the healthcare system began collecting electronic 
medical records, as well as when they implemented the use of ICD-9 codes. Some 
electronic medical record systems date back to the 1960s, but the majority of robust 
records were documented in the 1990s and early 2000s (Atherton, 2011).  
The study by Croen et al. (2015) was the first to present prevalence of co-
occurring conditions in adults with ASD using diagnostic codes. The aim of the study 
was to capture a large sample of individuals with ASD and compare prevalence rates to a 
control cohort. The study contributed a large amount of information to the field and 
presented the first example of using diagnostic codes in this population (Croen et al., 
2015). This method allows researchers to more easily investigate a larger number of 
individuals; however, the validity of these large medical data sets for this type of analysis 
is unknown.  
This dissertation study aimed to investigate this concept. I had access to a large 
data set that (1) contained in-person assessments of intellectual and adaptive behavior, 
co-occurring psychiatric and medical conditions, and (2) was linked to the UPDB for 
matching with medical billing records of the two largest healthcare systems in Utah. This 
data set allowed me to compare the presence of co-occurring anxiety identified through 
an in-person semistructured interview to the presence of co-occurring anxiety identified 
through medical billing records. Also, it allowed the researchers to present the prevalence 




outcome variables. Overall, the aim was to improve our understanding of co-occurring 
anxiety in adults with ASD, as well as our understanding of research methods and data 
sources. 
Main findings from these questions are discussed in the following sections. 
Overarching themes from the research findings are discussed as well. A larger concept 
appears to be an ongoing issue of co-occurring psychiatric condition identification and 
definition. In other words, there is a significant amount of variability in the prevalence of 
co-occurring anxiety based on its measurement methods. In addition, there are both 
clinical and investigation implications for this research, such as access to healthcare and 
service delivery or development. 
 
Demographic Considerations 
The ASD cohort used for this dissertation was comprised of participants from the 
three studies conducted through the University of Utah Autism Research Program. The 
ASD cohort consisted of participants with differing levels of intellectual functioning and 
adaptive behaviors, as well as a wide age range and a variety of ASD symptomatology. 
While the sample showed some diversity in abilities and ASD symptoms, it was also 
limited, given that a large number of participants were ascertained through a study 
originally conducted in the 1980s. This study, an epidemiologic survey conducted in the 
1980s, aimed to investigate the prevalence of autism in Utah (Ritvo et al., 1989). The 
sample was identified using DSM-III criteria for autism. Twenty years later, investigators 
were interested in this population of participants, particularly as to what type of life 




abilities had changed (Farley et al., 2009).  In addition, investigators were interested in 
the impact changes in DSM criteria for autism had on ASD case status of participants 
who originally did not meet DSM-III criteria for autism. Sixty-four participants were 
reclassified using CDC ADDM Network chart review methodology and reascertained for 
the follow-up study if they were originally or reclassified as having ASD (Miller et al., 
2013). The cohort for this dissertation was primarily drawn from this follow-up study, 
providing a rich, longitudinal perspective of adaptive and intellectual ability, and recent 
outcomes from semistructured assessments of co-occurring psychiatric conditions, 
medical conditions, and employment outcomes.  In addition to these individuals, 
participants were ascertained from a study investigating transition into adulthood and 
genetics of individuals with ASD (Farley et al., 2009). Participants from all three samples 
were collapsed into one sample for this dissertation and extraction of medical billing 
records.   
This sample was very specific to the state of Utah and included a large number of 
participants with a classic presentation of ASD as well as a more contemporary 
understanding of the broader ASD spectrum as reflected in the IQ distribution among 
participants described in Table 12. For example, studies by Howlin, Mawhood, and 
Rutter (2000) and Helles, Gillberg, Gillberg, and Billstedt (2015) included a similar 
population of participants who were ascertained with inclusion criteria based on previous 
versions of the DSM. However, the majority of adult outcome literature utilized samples 
of adults who were ascertained in the 1990s or 2000s (Billstedt, Gillberg, & Gillberg, 
2005; Barneveld, Taylor, Henninger, & Mailick, 2015). These samples comprise more 




The sample was specific to the region of Utah, as a large majority was ascertained 
through the epidemiological survey study.  This includes a large number of rural areas 
that tend to be somewhat secluded from healthcare resources. The participants had access 
to services in a growing metropolitan area, but this sample is likely to differ largely from 
a sample of participants ascertained in a larger, more established metropolitan area. 
Living in a rural setting could reduce a participant's access to services and potentially the 
quality of services they receive, yet these individuals may also experience better social 
outcomes in regards to their inclusiveness in their small communities and tightness of 
their social network.  Previous reports on a subsample used for this dissertation suggested 
that the adults in this study had somewhat better social outcomes when compared to 
adults in other follow-up studies. It was hypothesized that the social support and structure 
provided by a local religious organization might have influenced more positive results 
(Farley et al., 2009). 
 
Use of Diagnostic Codes to Present Prevalence  
This study aimed to investigate the use of diagnostic codes to present prevalence 
of co-occurring psychiatric conditions. Large data, some of which consists of diagnostic 
codes from medical billing records, are more frequently used to investigate findings on 
adult outcomes. For example, Roux et al. (2015) published the National Autism 
Indicators Report: Transition Into Young Adulthood 2015 using data from a large 
database holding survey data from several studies. This report included, among several 
factors, service usage, health and mental health care, education, and employment (Roux 




with ASD, with the exception of one study from Croen et al. (2015). The use of large data 
could be a cost- and time-efficient method of data collection, but it is unknown as to 
whether these are reliable. I aimed to evaluate how diagnostic codes compare to an in-
person, gold-standard assessment of co-occurring anxiety for adults with intellectual 
disability. Along with the comparison between the two measures, I was interested in 
strengths and weaknesses of diagnostic codes for estimating the prevalence of co-
occurring anxiety. 
First, the comparison between diagnostic codes and the Mini PAS-ADD is 
discussed. The reliability of diagnostic codes is considered through tests of association 
and correlations. Validity is considered using estimates of sensitivity and specificity. 
Positive predictive values and negative predictive values are discussed in relation to 
probabilities of diagnostic codes correctly identifying co-occurring anxiety. Lastly, the 
overall strengths and weaknesses of diagnostic codes, as well as implications for clinical 
and research purposes are discussed.   
 
Reliability of Diagnostic Codes  
To investigate the reliability of diagnostic codes, diagnostic code data were 
compared to data from the Mini PAS-ADD, a semistructured clinical interview. 
Significant associations were found for each anxiety variable, indicating a relationship 
between the two data sources. The associations were significant when assessed at an 
alpha of 0.05.  Specifically, p-values were as follows: OCD (p < 0.001), Anxiety (p = 
0.035), and Anxiety/OCD (p = 0.048).  These associations suggest that case status for 




The relationship signifies that diagnostic code data could be used to present prevalence of 
co-occurring disorders, as there was some relationship between data. This relationship 
was also visible in the prevalence rates of overall co-occurring anxiety. When the 
measures were used independently to measure prevalence, the proportions were rather 
similar, suggesting similarities in the measurement tools. The associations and visual 
similarities suggest concordance between the two measures; however, more research in 
this area is warranted given two of the significance values approached the .05 limit. 
Statistical tests, like the chi-square, are subjective to sample size. A varying sample size 
could impact the significance of the Pearson chi-square.  
In addition to chi-square associations, Spearman’s correlation coefficients were 
calculated between the two data sources. If significant, the strength of the relationship 
was evaluated based on Cohen’s recommendations (Cohen, 1988). Significant correlation 
coefficients were found for all variables but the correlations were weak, with the 
correlation for OCD approaching moderate strength. The weak correlations signify 
poorly aligned data between measures. While there is a significant relationship between 
the data sources, they do not appear to be measuring the same concepts.  
No other studies related to autism have been conducted in this area; however, in 
other studies comparing two measurements, researchers decided that comparable 
correlations were insufficient and suggested that the measures were described 
phenomena. Indeed, this finding reflects the larger issue of measurement differences 
between billing code data and in-person, semistructured assessments designed for adults 
with a developmental disability. Measurement differences may be attributable to a variety 




range of billing code ascertainment, distinctions in the scope of practice between 
community providers (diagnostic billing codes), and research-reliable clinicians 
administering this specific assessment tool designed for this purpose. For example, the 
Mini PAS-ADD directly assesses for the presence of co-occurring anxiety, using a cutoff 
score indicating diagnostic status. Community providers, frequently practicing under 
significant time constraints, tend to assess symptoms from the context of what may 
respond to medication rather than closely following diagnostic criteria, particularly when 
treating this population. If the topics discussed in that episode of care do not closely 
reflect the presence of an anxiety disorder, it is unlikely further query will occur to elicit 
anxiety disorder criteria and subsequent assignment of the diagnostic code. In addition, it 
is also unclear to what degree general community providers directly assess anxiety 
symptoms and whether they provide a diagnostic code for this diagnosis if observed.  
Even within the control population, the most common anxiety diagnostic billing code 
identified corresponded to anxiety disorder NOS rather than a specific anxiety disorder 
such as generalized anxiety disorder. 
Overall, the two data sources were found to be associated but with weak 
correlations. Diagnostic codes do not identify co-occurring anxiety in the same way that a 
semistructured interview might. Sterling et al. (2015) compared a revised measure of 
anxiety and depression in children with ASD to several existing measures of anxiety in 
children. Only a few significant correlations were found, with correlations ranging from 
.26 to .35. The authors concluded that these measures were not strongly related and the 
uses of all measures should be further investigated. Study researchers also felt that the 




anxiety but with certain cautions (Sterling et al., 2015).  The significant association 
between the two data sets used for this dissertation reflects a similar concept. However, 
this study differs from other studies where two specific assessment methods were 
compared to one another, as the diagnostic codes came from community diagnoses, 
which tend to originate from clinician impression based on history and presentation rather 
than a formal measure of anxiety. The co-occurrence of ASD with or without intellectual 
disability further negates the use of common anxiety screeners in clinical settings, further 
influencing the correlation of diagnostic codes to the Mini PAS-ADD. The weak 
relationship between anxiety case status between Mini PAS-ADD and diagnostic billing 
codes indicates the need for caution when relying on diagnostic code data in isolation. 
While the Mini PAS-ADD was used as the gold standard measure in this study, 
limitations exist with this tool as well. Lifetime case status is based on recall, which can 
be variable depending on the temporal proximity of symptom episode as well as the 
caregiver's familiarity with the participant and their history. When determining which 
method to use to measure co-occurring anxiety, the Mini PAS-ADD may provide more 
reliable information, as it has been found to be a reliable source in several research 
studies with a variety of populations (Prosser et al., 1998). The Mini PAS-ADD appears 
to be one of the best tools to measure co-occurring conditions the field has thus far. 
However, the diagnostic code data may provide a historical reference independent of 
informant memory. Further investigation of when the Mini PAS-ADD was administered 
and when a diagnostic code was assigned may inform the discrepancy found between 





Validity of Diagnostic Codes  
Diagnostic code data were found to be associated but weakly correlated with data 
from the Mini PAS-ADD. Sensitivity and specificity estimates were calculated to reflect 
the validity of diagnostic codes when compared to the Mini PAS-ADD. These estimates 
were derived from cross-tabulations where diagnostic code case status was compared to 
case status from the Mini PAS-ADD. The Mini PAS-ADD lifetime diagnosis of co-
occurring anxiety was considered to be the true diagnostic status for participants. 
Sensitivity is the proportion of participants with a lifetime history of anxiety identified on 
the Mini PAS-ADD who had a diagnostic billing code corresponding to an anxiety 
disorder.  Specificity is the proportion of participants without a lifetime history of anxiety 
based on the Mini PAS-ADD who had no diagnostic code corresponding to an anxiety 
disorder. Sensitivity and specificity estimates somewhat work together. An ideal test 
would have both high sensitivity and high specificity, meaning that the test can accurately 
identify both those with the disease and exclude those without the disease. This is 
somewhat rare. For studies similar to this one, there are no suggested values or qualifiers 
to determine expectations for sensitivity or specificity estimate. Statistical research 
papers suggest that clinical judgment is used in determining whether an estimate is 
acceptable. For the purpose of this study, it would be ideal to have a highly sensitive test, 
as that would indicate that diagnostic codes had identified a large number of participants 
with anxiety. While a highly specific test has benefits, as it would detect the individuals 
without the disorder, the purpose of this study is to identify and present the number of 
participants positive for a co-occurring anxiety disorder. Some statistical papers suggest 




positive test are likely to have the disorder (Akobeng, 2006). While this is a suggested 
use of the specificity estimate, this concept is somewhat irrelevant to this research study. 
Again, the larger purpose of the study was to evaluate the prevalence, or presence, of 
anxiety in adults with ASD using diagnostic codes. 
Overall, the sensitivity estimates were inadequate in identifying participants with 
anxiety. The sensitivity estimate for Anxiety suggests that about 55% of the participants 
with anxiety were detected with diagnostic codes. This estimate is not sufficient for 
identification of anxiety. Of the 113 participants identified as having anxiety with the 
Mini PAS-ADD, only 62 of them were found to have anxiety through diagnostic codes. If 
diagnostic code data were solely being used to report the prevalence of anxiety, 51 
participants, or 45%, would not be accounted for. More research is warranted to 
investigate why these participants were not identified by diagnostic code data. This has 
implications for both the clinical and research communities. From a research standpoint, 
it is important to identify why these participants were identified with diagnostic codes. 
Perhaps diagnostic codes are better at identifying co-occurring anxiety in a specific 
subsection of adults with ASD. Clinically, it would be good to identify why diagnostic 
codes missed almost half of the adults with ASD, as they could benefit from an 
intervention aimed to ameliorate symptoms of anxiety. 
The specificity estimate for Anxiety was higher, indicating that diagnostic codes 
identified 60% of the participants without anxiety. This higher specificity estimate 
suggests that the diagnostic codes were better at identifying those without anxiety. With 
that said, a specificity estimate of 60.5 is not highly specific but specificity appears to be 




 The sensitivity and specificity estimates were much stronger for the variable of 
OCD. The sensitivity estimate for OCD was very low and the specificity estimate was 
very high. This indicates that diagnostic codes are very good at identifying those without 
OCD and not good at identifying those with OCD. For measurement and clinical 
purposes, it would be much more beneficial for diagnostic codes to identify those with 
OCD. The low sensitivity estimate for OCD could reflect the challenge providers face 
when attempting to identify OCD in individuals with ASD, as there is a large amount of 
symptom overlap.  
When anxiety and OCD were collapsed into one variable, the sensitivity and 
specificity estimates followed a different pattern. The sensitivity estimate was higher, 
indicating that the diagnostic codes captured a larger proportion of the participants with 
anxiety. The specificity estimate was slightly lower. This suggests that when anxiety and 
OCD are measured together, diagnostic codes are better at capturing more participants 
with anxiety or OCD. It may be beneficial to consider this in the future development of 
anxiety measures for this population.   
 Diagnostic code data were found associated with but weakly correlated to data 
from the Mini PAS-ADD. The sensitivity estimates for all variables suggest that 
diagnostic code data accurately identified only half of the participants with a co-occurring 
anxiety disorder. This also suggests that the other half of the participants with anxiety 
were not identified. There are many reasons why an individual with an anxiety disorder 
might not have a diagnostic code in their medical record, but it is important to reiterate 
that the diagnostic code data missed a large proportion of the participants who were 




diagnostic code data.  
The specificity estimates for Anxiety and Anxiety/OCD suggested that diagnostic 
code data accurately identified 50-60% of the participants without a co-occurring anxiety 
disorder. This estimate is higher, indicating that more of the sample was correctly 
identified as not having the disorder. This information continues to demonstrate the 
limited abilities of diagnostic code data to accurately identify individuals with or without 
co-occurring anxiety. Several possible reasons for this inadequacy exist. For participants 
who were incorrectly identified as having anxiety by the diagnostic codes, meaning they 
were not captured as having anxiety by the Mini PAS-ADD, it is possible that the 
individual providing information to the Mini PAS-ADD forgot about a previous time 
when the participant was exhibiting symptoms. It is also possible that the participant's 
total score for anxiety on the Mini PAS-ADD fell just below the cutoff, a limitation 
demonstrated by some low sensitivity estimates for anxiety on this measure (Janssen & 
Maes, 2013). It is also possible that participants exhibited signs of anxiety or received a 
diagnostic code for anxiety after the Mini PAS-ADD was administered. For participants 
who were not identified by diagnostic code data, it is possible their providing clinician 
was unable to assess for anxiety due to limited verbal abilities. It is also possible that 
their provider identified an anxiety disorder but was not directly treating the disorder, and 
therefore did not submit a diagnostic code for co-occurring anxiety. While the sensitivity 
and specificity estimates of diagnostic codes approached ranges that could be considered 
acceptable, they speak to the limitations of the diagnostic code data. 
Sensitivity and specificity estimates are widely used for test development in both 




determine how well a test is or is not measuring a concept during the test development 
process. Although some papers provide recommended estimates to use for measuring 
efficiency or acceptability of a measure, these recommendations are less applicable when 
evaluating sensitivity and specificity for binary variables. Overall, the research indicates 
that clinician judgment is the best suggestion when determining if a sensitivity or 
specificity estimate is appropriate. It is suggested that the clinician decide whether it is 
more important to correctly identify someone with the disease using sensitivity and have 
a lower threshold for ruling out the disease or vice versa (Akobeng, 2006). For this study, 
I felt that it was more important to correctly identify a participant with the disease. Given 
this decision, the sensitivity estimates were quite insufficient, only correctly identifying 
half the participants with anxiety. The other half of participants identified as having 
anxiety with the Mini PAS-ADD were not identified with diagnostic billing codes. 
Because billing codes reflect clinical assessment and treatment, this suggests that in a 
substantial minority of adults with ASD, anxiety is present but unrecognized and 
untreated. When we consider using diagnostic codes for the identification of participants 
with anxiety, it should be advised that these data are missing a significant number of 
individuals with the disorder and underestimating the actual prevalence.  
 
Strengths and Weaknesses of Diagnostic Codes  
Positive predictive values and negative predictive values were calculated and 
provide insight into the strengths and weaknesses of diagnostic codes when compared to 
the Mini PAS-ADD. The positive predictive value is the probability that a participant 




negative predictive value is the probability that a participant with a negative test result is 
actually absent of the concept being measured. In the case of this dissertation, the positive 
predictive value is the probability that a participant with a diagnostic code case status 
positive for anxiety actually has anxiety. The negative predictive value is the probability 
that a participant with a diagnostic code case status negative for anxiety is actually 
without anxiety. These values describe the probability of actually having or not having 
anxiety as determined by the diagnostic code case status. These values are discussed 
based on the different variables and reflect potential strengths for measurement of anxiety 
in this population using diagnostic codes. 
 When diagnostic codes were used to measure Anxiety, the probabilities of a test 
result being correct were fairly low. The probability that a participant with a positive test 
for anxiety was correct was only 66%, meaning 1/3 of the participants potentially had an 
inaccurate test result. The probability that a participant with a negative test for anxiety 
was correctly identified as being absent of co-occurring anxiety was only 49%. These 
numbers suggest poor probability that a diagnostic case status is correct.  
 The positive and negative predictive values for OCD were slightly more 
acceptable with a positive predictive value of 62.5% and negative predictive value of 
70.5%. Similar to the sensitivity and specificity estimates for OCD, the diagnostic codes 
appear to be more accurate in identifying those without the disorder. The negative 
predictive value for OCD suggests that the probability of being absent of OCD is 70%, 
which is fairly high.  
The positive and negative predictive values changed significantly when Anxiety 




changes in the sensitivity and specificity estimates. The positive predictive value suggests 
that the probability of actually having anxiety with a positive case status for anxiety is 
73%. The negative predictive value was much lower at 39.8%, suggesting only a 40% 
chance of not having anxiety given a negative case status for anxiety. When the concepts 
were collapsed, the probability of actually having anxiety based on a diagnostic code 
increased.  
 The positive and negative predictive values describe the probability of actually 
having a correct case status from diagnostic billing codes. These values suggest that the 
probability of the diagnostic codes being correct is fairly low for the majority of the 
factors, with the exceptions of being case status negative for OCD and case status 
positive for Anxiety/OCD. When considering whether or not diagnostic codes are an 
acceptable measure of anxiety in adults with ASD, the probability of a case status being 
correct is low and suggests that diagnostic codes are an unpredictable measure of anxiety 
in this population.  
 
Uses of Diagnostic Billing Codes 
 The larger aim of this dissertation was to evaluate the use of diagnostic codes to 
measure anxiety in adults with ASD. While the diagnostic codes were significantly 
associated and correlated with Mini PAS-ADD measurements of anxiety, the correlations 
were low. The sensitivity, specificity, positive predictive values, and negative values 
were all relatively low as well. These analyses indicate that diagnostic codes are not good 
at capturing those with or without anxiety and the probability of a case status being 




this dissertation, it was decided that while the reliability and validity indicators were low, 
it was still acceptable to use diagnostic codes to present the prevalence of co-occurring 
anxiety in this population. That decision was made based on three factors: there were 
significant associations between diagnostic codes and the Mini PAS-ADD; there were 
significant correlations found between the data; and the prevalence estimates were 
relative similar when compared visually. Diagnostic codes were used to present the 
prevalence of co-occurring anxiety in adults with ASD and the control cohort, with the 
understanding that this is purely an estimate of co-occurring anxiety in this population. 
Data from the Mini PAS-ADD were prioritized and used first when possible.  
One larger concept to discuss is the one of measurement. The diagnostic codes 
were not sensitive, specific, or well correlated with the Mini PAS-ADD. This indicates 
and reflects a larger measurement issue occurring in this area of research. One issue is 
that while the Mini PAS-ADD is suggested to be a reliable and accepted assessment tool 
to evaluate co-occurring psychiatric conditions, the sensitivity rates were found to vary 
from 40% to 80% (Janssen & Maes, 2013). Another study found the sensitivity to be 
100% (Devine, Taggart, & McLorian, 2009). The specificity of the Mini PAS-ADD 
ranged from 71% to 100% (Devine, Taggart, & McLorian, 2009; Janssen & Maes, 2013). 
This suggests that this measure also varies in the ability to measure co-occurring 
psychiatric disorders in this population. The diagnostic codes reflect community provider 
practices surrounding the diagnosis, and likely treatment of anxiety. The Mini PAS-ADD 
measures current and lifetime anxiety based on caregiver's observations and recall of 
anxiety diagnostic criteria. The difference in the end result of anxiety case status between 




reliable methods of measuring anxiety in individuals with ASD in the community setting.   
There is some existing literature that discusses the use of diagnostic codes to 
investigate the prevalence and speaks to various measurement considerations. These 
studies are not focused on ASD but provide insight into how diagnostic codes were found 
to be beneficial or show limitations in other areas. Denny (2012) speaks to issues of 
collecting data from electronic health records. This author discusses several studies with 
findings similar to the results described in this dissertation, with diagnostic codes having 
poor sensitivity and specificity. However, this chapter by Denny (2012) also addresses 
the findings from several studies that indicate higher sensitivity and lower specificity of 
diagnostic codes. There are suggestions that billing codes providing information on 
procedures were more specific than diagnostic codes providing information on diagnoses. 
The consensus from this review of the literature was that diagnostic codes could be used 
to present findings but might be better used as a screening method (Denny, 2012). The 
findings in this dissertation are similar in that the diagnostic codes appear to be 
measuring something similar to the Mini PAS-ADD and might serve as a good screening 
method to then do further assessment of co-occurring anxiety. 
Several other studies presented findings comparing diagnostic codes to 
standardized measures. Wang, Laud, Macias, and Nattinger (2010) compared ICD-9 
codes to operative notes from spinal surgeries. These authors found that ICD-9 codes had 
low sensitivity and high specificity with more specific diagnoses, much like the OCD 
diagnostic code sensitivity and specificity estimates found in this dissertation (Wang et 
al., 2010). When (Campbell et al., 2011) evaluated diagnostic codes compared to an in-




represented prevalence. This was displayed in this dissertation. When co-occurring 
anxiety was independently used to present prevalence, the rates were much lower.   
 Croen et al. (2015) were the first to use diagnostic codes to present prevalence on co-
occurring psychiatric conditions. Kohane et al. (2011) used diagnostic codes to 
investigate comorbidity burden in children and young adults with ASD. Their study 
focused on epilepsy, schizophrenia, inflammatory bowel disease, bowel disorders, sleep 
disorders, muscular dystrophy, diabetes mellitus, cranial anomalies, and autoimmune 
disorders. The authors commented on the use of diagnostic codes to report the prevalence 
of these disorders. They mentioned a problem with inclusion criteria for participants with 
ASD, as many of the participants visited several hospitals queried and the participants 
may have been counted twice. Prevalence of disorders found in the ASD population study 
was similar but discrepant from prevalence rates found in other studies (Kohane et al., 
2011). Similar discrepancies were observed in this dissertation as well. Lastly, Kohane et 
al. (2011) suggested using diagnostic codes to first identify participants at-risk and then 
potentially using natural language processing to pull information from electronically 
stored clinical notes (Kohane et al., 2011).   
The existing literature is consistent in that all discussions suggest further research 
in this area to strengthen our understanding of how or when to use diagnostic codes to 
investigate prevalence. In addition to implications for further research, there are some 
clinical implications for the use of diagnostic codes. While it would be beneficial to 
measure the rates of anxiety in this population, clinically, it is important to identify these 
individuals. Specifically, when sensitivity is considered, it would be preferable that 




would suggest that individuals with anxiety would be identified and subsequently treated 
for anxiety. Given the symptom overlap between anxiety and ASD, as well as large 
numbers of anxiety symptoms in this population, a false positive, or subthreshold level 
for meeting diagnostic criteria, may not be detrimental in this scenario. Limited 
communication abilities and problem behaviors could be impacting the sensitivity of this 
test. Interestingly, participants with severe intellectual and/or communication deficits 
represented a higher than expected proportion of those with anxiety, which is important 
information for providers to consider when conducting assessments. 
 
Co-occurring Anxiety in Adults With ASD 
There are several factors to discuss regarding co-occurring anxiety in adults with 
ASD. First, it is important to compare the rates of anxiety found in this study to rates 
found in other studies, particularly comparing the rates to the only other study that used 
diagnostic billing codes to report the prevalence of co-occurring anxiety. Second, it is 
important to note the types of anxiety disorder diagnoses found and the lack of specificity 
in these diagnoses. Third, the rates of anxiety differed depending on how anxiety was 
measured, either with an in-person semistructured interview or through diagnostic code 
data. While diagnostic code data were found to have low sensitivity and specificity and 
were weakly correlated to the Mini PAS-ADD, these data were included in anxiety case 
status determination as it provided a larger sample size from which to compare findings 
from this dissertation to those prevalence rates reported in other research studies.  
Some studies have investigated the prevalence of co-occurring anxiety in adults 




Gillberg, Helles, Bilstedt, and Gillberg (2016) 2016 found that out of 50 adults with 
Asperger syndrome, only three had never met criteria for an anxiety disorder (Gillberg et 
al., 2016). Lever and Geurts (2016) found that in a large sample of adults with intellectual 
quotients greater than 80, only 18.3% of participants met criteria for anxiety from a 
symptom checklist. This estimate was much lower than the proportion of participants in 
this dissertation. Charlot et al. (2008) identified a similar proportion of 62% of adults 
receiving inpatient services met criteria for anxiety.  Lugnegard, Hallerback, and Gillberg 
(2011) reported that 50% of the sample presented with co-occurring anxiety disorders. 
Mazefsky, Folstein, and Lainhart (2008) reported 59% and 41% of their sample to have a 
co-occurring anxiety disorder. Hofvander et al. (2009) also reported that anxiety 
disorders were the most common found in a study of adults with normal cognitive ability. 
These prevalence rates of anxiety are found in Figure 1. Some of these studies displayed 
similar prevalence rates in adults with ASD; however, all of these studies varied in 
sample size, population, and measurement tools used to evaluate for co-occurring 
anxiety. Interestingly, many studies of anxiety in adults with ASD consider the lifetime, 
rather than the current anxiety symptoms.  
For this dissertation study, the percentage of participants with co-occurring 
anxiety and anxiety/OCD was 58.2% and 67.3% with the Mini PAS-ADD and 46.6% and 
50.0% with diagnostic codes, respectively. When the Mini PAS-ADD was used to 
present the prevalence of anxiety, it was the third highest rate of anxiety when compared 
to other studies. The diagnostic code data yielded lower rates of anxiety, Anxiety, 46.4%, 
which was more consistent with other studies, where estimates were found to be 50% 




diagnostic code data appeared to be slightly more conservative but provided a similar 
estimate of co-occurring anxiety in this population. The sample size used for this study 
was much larger than those of previous studies, which could indicate that these studies 
are not capturing a large portion of adults with ASD who also have co-occurring anxiety. 
Overall, this study revealed a similar prevalence rate to a number of other studies. 
There is only one other study to date that has used diagnosed codes to present the 
prevalence of co-occurring psychiatric conditions (Croen et al., 2015). Croen et al. (2015) 
presented data on the prevalence of a variety of co-occurring psychiatric and medical 
comorbidities in a sample of over 1000 participants. This study reported that 29% of their 
population presented with a co-occurring anxiety disorder. This is far less than the 
proportion found in the current study, as well as the proportions presented in other 
samples and studies. The sample size in the Croen et al. (2015) study was much larger, 
but case status of ASD was determined differently. Croen et al. (2015) identified 
participants with ASD based on diagnostic codes for those disorders. Two diagnostic 
codes for ASD were required for inclusion in the study (Croen et al., 2015). This is very 
different from the current study, which used more comprehensive methods of identifying 
participants identifying participants with ASD and based ASD case status on in-person 
assessments. Another difference between this dissertation and the study by Croen et al. 
(2015) was that Croen et al. (2015) used slightly different and fewer diagnostic codes to 
identify anxiety. In fact, Croen et al. (2015) only used seven diagnostic codes, while this 
dissertation study used 13. Both of these factors return to a larger issue of measurement 
variations, as both participant inclusion criteria and method of measuring co-occurring 




of co-occurring anxiety, 46.4-58.2%, than the 29% presented in the study by Croen et al. 
(2015). 
 The overall prevalence of co-occurring anxiety was presented through an 
indicator variable that incorporated all diagnostic codes for anxiety. Frequencies and 
proportions for specific diagnostic codes were also presented. The most common 
diagnostic code was anxiety state, unspecified (n = 179, 43.4%), followed by generalized 
anxiety disorder (n = 69, 19.2%) and social phobia (n = 11, 3.1%). All other diagnostic 
codes had frequencies of 10 or less. This happened to be the case for the control cohort as 
well, indicating that healthcare providers are not utilizing specific diagnostic codes in 
medical records. The diagnostic code data lacked the distinction among specific anxiety 
disorders. The Mini PAS-ADD also lacks diagnostic indication for specific anxiety 
disorders, as was used in other studies that focused on specific anxiety disorders like 
social anxiety (Maddox & White, 2015; Swain et al., 2015). Due to insufficient data from 
both data sources, I was unable to comment further on the presentation of anxiety 
diagnoses found in this population.   
 Lastly, the prevalence of co-occurring anxiety was presented using both Mini 
PAS-ADD and diagnostic code data. These data sources were combined to present the 
prevalence of co-occurring anxiety when either measure was used. The proportions of 
anxiety differed significantly depending on which measurement tool was used. The 
proportion of all anxiety variables was the largest when the Mini PAS-ADD was used to 
identify co-occurring anxiety. In fact, the proportion of the overall anxiety variables was 
12 to 17 percentage points lower when diagnostic code data were used to investigate 




most similar to estimates from the Mini PAS-ADD.  
 
Prevalence of Anxiety - Comparison Between Adults 
With ASD and Controls 
The prevalence of co-occurring anxiety in adults with ASD was compared to 
anxiety in same age-and sex-matched controls. Significant associations were found for 
each variable, and the proportion of anxiety was higher in adults with anxiety than in 
controls. Previous research comparing prevalence rates of co-occurring anxiety between 
typically developing controls to adults with ASD have found similar findings (Croen et 
al., 2015; Hare et al., 2015; Swain et al., 2015). Overlapping symptomatology between 
anxiety and ASD could be responsible for higher prevalence rates of co-occurring anxiety 
in adults with ASD; however, the majority of the literature is currently suggesting that the 
prevalence rate goes beyond the presence of symptoms and suggests that more 
individuals with ASD also meet criteria for a full anxiety disorder compared to typically 
developing peers (Kerns & Kendall, 2013; Kerns et al., 2014).    
The ASD cohort demonstrates a higher rate of anxiety disorders overall and 
among individual diagnoses than in the control cohort. Given the symptom overlap 
between anxiety and ASD, as well as the expressive language impairment frequently 
experienced in adults with ASD, one might think that providers would be more inclined 
to give an adult with ASD an unspecified diagnosis rather than an adult without ASD. 
However, the control cohort also had a paucity of specific diagnostic codes 
corresponding to an anxiety disorder beyond unspecified anxiety state. This suggests that 




Technically, the use of the unspecified anxiety disorder diagnosis was intended to capture 
those with an anxiety disorder that did not meet criteria for a more specific diagnosis 
(American Psychological Association, 2013; Medicode, 1996). The similarities in use of 
this diagnosis between cohorts suggest that time constraints may limit the query of more 
specific anxiety criteria or conducting further assessment of these anxiety symptom 
clusters. 
 
Prevalence of Anxiety - Comparison to  
National Prevalence 
The prevalence of co-occurring anxiety in adults with ASD and anxiety in a 
control cohort was compared to national prevalence rates. The national prevalence rates 
used for comparison were derived from a well-validated and widely accepted study that 
used a semistructured interview to evaluate prevalence rates in a very large sample of 
participants in the United States (Kessler et al., 2012). Kessler et al. (2012) presented 
prevalence findings on an all-encompassing variable of anxiety, including OCD, and 
some individual diagnoses. The national prevalence study report of higher specific 
anxiety disorder estimates likely reflected the direct ascertainment and use of a 
semistructured interview to obtain this information with the subsequent collection of 
detailed information needed to establish specific anxiety disorder diagnoses (Kessler et 
al., 2012).  Thus, the comparison between this study's findings from diagnostic billing 
code data with those of the national prevalence study lacks value for specific anxiety 
disorders because the majority of diagnostic billing codes in this study were for an 




ASD showed higher rates than found in the control cohort and reported in the national 
prevalence study, while the control cohort demonstrated lower anxiety rates than those 
reported in the national prevalence (Kessler et al., 2012). This difference between the 
control cohort and national prevalence study likely reflect the inherent disparity in 
identifying comorbid anxiety when using passive versus active participation study 
methodologies. The increased prevalence of co-occurring anxiety among adults with 
ASD, when compared to controls, suggests higher anxiety experienced by those with 
ASD. However, this finding may also be attributed to increased interaction with health 
care services, subsequently increasing the likelihood of receiving any anxiety diagnosis. 
Also, low sensitivity estimates found for diagnostic code data, in light of national 
prevalence study findings, suggest that using diagnostic codes exclusively may cause a 
large number of control participants who actually have anxiety to be missed. The findings 
from diagnostic code data should be considered with caution given the low sensitivity 
estimates of diagnostic billing codes. 
 
Prevalence of Anxiety – Comparison Between Sexes  
Existing research indicates that more females than males display certain anxiety 
disorders, such as specific phobias, panic disorder, or agoraphobia (American 
Psychological Association, 2013). Some prevalence estimates suggest that more males 
than females experience social anxiety disorder (American Psychological Association, 
2013). An exploratory analysis was conducted to evaluate potential sex differences in 
prevalence findings of anxiety in both the ASD cohort and control cohort. This analysis 




that data for both cohorts had a single source type of ascertainment.  
When the prevalence of co-occurring anxiety was compared between males and 
females in the ASD cohort, significant associations were found for all anxiety groups 
(i.e., Anxiety, OCD, Anxiety/OCD), with a higher proportion of females affected than 
males. In the control cohort, the only significant association with sex was for the 
combined Anxiety/OCD category, with a larger proportion of females affected. The 
higher proportion of anxiety found in females in the control cohort is consistent with the 
majority of current research findings (Kessler et al., 2013). However, the proportion of 
females in the control cohort was substantially lower than the proportion ascertained for 
Kessler et al. (2015). 
The higher rate of anxiety among in females with ASD has some clinical 
implications. It indicates a stronger need for providers to screen for anxiety in females 
with ASD. In addition, females with ASD tend to be more significantly impaired, 
including having more limited communication abilities (Frazier, Georgiades, Bishop, & 
Hardan, 2014; Rubenstein, Wiggins, & Lee, 2015). This reduced capacity to express 
internal experiences of anxiety merits a proactive approach by providers to query these 
symptoms in women with ASD.  
 
Co-occurring Anxiety and Intellectual or Adaptive Behavior 
 The presence of co-occurring anxiety was compared to intellectual functioning 
and adaptive behavior in the larger ASD cohort. These data were compared using chi-
square associations and descriptive analyses. Logistic regression analyses were conducted 




adaptive behavior. Both Mini PAS-ADD data and diagnostic code data were used to 
account for anxiety in this cohort. Significant associations were found for comparisons 
between intellectual functioning and Anxiety and Anxiety/OCD, but not OCD only. 
Significant associations were found for all anxiety variables and categories of adaptive 
behavior. Descriptive and demographic results are discussed, as well as significant 
findings in proportions of anxiety in the various categories and regression results.   
 
Anxiety and Intellectual Functioning  
The intellectual functioning demographics are worth discussing. Intellectual 
functioning abilities were broken out into three categories denoting normal IQ (FSIQ 
>70), mild ID (FSIQ = 50-69), and severe ID and untestable (FSIQ <50). Participants 
who fell into the category of untestable typically had significant behavior difficulties, 
which resulted in the inability to test, or additional disabilities that invalidated 
measurement tools. Many of these participants were determined to have severely 
impacted cognitive abilities, as determined through various other measures. For 
participants where this could be determined, they were included in the severe ID 
category. 
Overall, those with ASD and anxiety were disproportionately affected by severe 
intellectual disability and adaptive behavior across the categories of anxiety. The majority 
of the data in these analyses resulted from the Mini PAS-ADD, which was designed for 
use with individuals with varying degrees of intellectual disability. These findings 
indicate the presence of severe intellectual disability increases, rather than reduces, the 




implications, as many providers do not assess for co-occurring anxiety disorders in their 
clients with ASD and severe ID. Despite limited expressive language, adults with ASD 
and severe ID may still communicate their anxiety through certain behavior patterns that 
originate from feelings of fear or worry. The research on adults with ASD and severe ID 
who also experience co-occurring anxiety is sparse as most studies of co-occurring 
anxiety in adults with ASD exclude participants with intellectual quotients below 70. 
 
Anxiety and Adaptive Behavior  
 Adaptive behavior abilities were collapsed into similar categories as intellectual 
functioning. The VABS and VABS-II provide a good assessment of adaptive behavior 
and capture the abilities of the adults with ASD; however, the majority of participants 
obtained scores below 70 (n = 215). This represents a larger proportion than those 
participants with an intellectual ability score below 70 (n = 89) and demonstrates the 
substantial impairment ASD characteristics have on functional levels. Although measures 
of intellectual functioning provide descriptive categories for scores below 70, many 
adaptive behavior tests do not. In order to investigate more differences between 
participants based on adaptive behavior, I grouped the participants into three levels of 
adaptive behavior, similarly to those of intellectual functioning. While there was a better 
distribution across groups, a significant number of participants received scores below 50, 
indicating overall poor adaptive behavior in the sample overall. 
Significant associations were found for nearly all anxiety variables and categories 
of adaptive behavior, except for OCD and the Daily Living scale. The most significant 




more participants with severely limited adaptive abilities had anxiety. Regression 
analyses suggested that severely limited adaptive behavior abilities predicted anxiety. 
Similar to intellectual functioning, participants with severe Adaptive Behavior 
Composite, Communication, or Social scores were 1.3-3.6 times more likely to have 
anxiety. This was not the case for the Daily Living scale; no functional group within the 
Daily Living scale predicted anxiety or OCD. Implications of these findings mirror those 
of intellectual functioning and anxiety. Participants with significantly limited adaptive 
behavior abilities were more likely to experience anxiety. Further investigation is merited 
to explore whether limited adaptive abilities predispose an individual to anxiety and the 
degree to which, if at all, anxiety interferes with the development of adaptive behavior 
abilities. Impaired communication and social skills may make life more anxiety 
provoking. Alternatively, anxiety symptoms may make it more difficult for individuals to 
carry out everyday interactions and to develop communication abilities. More research is 
warranted on this topic, as results could have implications for the development of 
interventions aimed at reducing anxiety or improving communication or social abilities. 
 
Co-occurring Anxiety and Employment  
The final aim of this dissertation was to evaluate the association between co-
occurring anxiety and employment. The presence of anxiety was compared to 
employment status and use of vocational rehabilitation. The current literature on adults 
with ASD shows that many adults with ASD have poor employment outcomes (Roux et 
al., 2015; Roux et al., 2013; Wei et al., 2015). This phenomenon is even true for adults 




employed (Gotham, Brunwasser, & Lord, 2015). The literature on individuals with 
mental health disorders, who are absent of ASD, suggests that these disorders can impact 
one’s ability to obtain meaningful education and employment outcomes (Mojtabai et al., 
2015a; Mojtabai et al., 2015b). These studies indicated that typically developing 
individuals with anxiety had lower odds of attending college and being employed 
(Mojtabai et al., 2015a). Murphy et al. (2009) also reported that having OCD was 
associated with impairments socially, personally, and vocationally. Several researchers 
who have reported findings on adults with ASD hypothesized that adults with ASD could 
be impacted further in their ability to gain employment if they also had co-occurring 
anxiety (Farley et al., 2009; Henninger & Taylor, 2013). This concept was explored in 
this dissertation through associations between anxiety and employment factors and 
regression analyses.  
Significant associations were found between employment status and all anxiety 
variables, indicating that employment status was inversely associated with the presence 
of an anxiety disorder. The most apparent differences in the data were found between 
those unemployed with anxiety, as more participants with anxiety were unemployed. 
Another interesting finding was that a large number of participants with supported 
employment experienced anxiety as well. Participants without anxiety were more likely 
to be independently employed. Regression analyses demonstrated that Anxiety, OCD, 
and Anxiety/OCD were significantly associated with supported employment. OCD 
significantly predicted supported employment. These findings support the hypothesis that 
anxiety may negatively impact one's ability attain independent employment. No existing 




exploration. It would be interesting to investigate further the factors linking anxiety and 
employment status in adults with ASD.   
 
Study Limitations  
This dissertation provides several contributions to the current literature base but is 
not without its limitations. The sample size, particularly the size of the sample used for 
the comparisons of in-person records to diagnostic codes, was limited. The sample was 
also skewed towards certain demographics. Next, the Mini PAS-ADD used to assess for 
the presence of co-occurring anxiety had its limitation. The sample used for comparison 
of in-person records to diagnostic billing code records was smaller than desired, which 
impacted the power of statistical analyses. Lastly, there are some limitations in how these 
data and analyses can be interpreted. 
This study was limited by sample size and demographics. While there were a 
substantial number of participants in the full ASD cohort, only half of those participants 
had both in-person records and diagnostic codes available for comparison. This 
significantly impacts the power of the analysis. The sample was also limited by 
demographics. Given that a large number of participants were ascertained in the 1980s, 
the sample was somewhat limited to an outdated concept of autism spectrum disorder. 
However, the inclusion of participants more recently ascertained and those reclassified as 
having ASD from the original 1980s cohort allowed for a representative sample of adults 
less severely impacted by ASD, suggested by the presence of normal intellectual 
functioning in 61% of the ASD cohort. Lastly, sample demographics were very specific 




US population. Studying psychiatric comorbidity among participants from rural areas is 
also problematic to the degree limited access to healthcare services is reflected in 
comorbidity presence. 
The study was also limited in the tools used for measurement and analyses. 
Although the Mini PAS-ADD has been studied reliably for the measurement of co-
occurring psychiatric conditions in adults with developmental disabilities, some studies 
report limited sensitivity and specificity when compared to trained clinician assessments 
(Prosser et al., 1998).  This instrument provided this study's gold standard for psychiatric 
comorbidity in several of the main analyses, in particular for the validation of diagnostic 
billing code use. 
Lastly, diagnostic code data were used in this study for a variety of purposes. 
Diagnostic codes, as displayed in this study, are limited in their measurement properties 
and subject to clinician and organization bias. Diagnostic codes are primarily populated 
for billing purposes rather than directing clinical care. It is possible that clinicians are 
treating individuals for anxiety but implementing another billing code or none at all, 
leading to the absence of diagnostic code for anxiety when an individual truly has 
anxiety. Our sensitivity findings for this diagnostic billing codes supports this conclusion: 
the absence of diagnostic code for anxiety acts as a poor predictor in whether anxiety has 
been considered and/or ruled out as a diagnosis. 
 
Implications for Future Research  
The current study has many implications for further research. Further analysis of 




status of anxiety. This research study could be expanded in sample size and to other 
psychiatric conditions. Diagnostic codes should be compared to different measures of 
psychiatric conditions and the measurement implications should be further evaluated. 
Lastly, the associations found between anxiety and intellectual functioning, adaptive 
behavior, and employment status prompt further investigation into the cause and effect 
nature of these relationships and subsequently, implications for anxiety treatment and 
adaptive skill development.   
This dissertation had a focused scope and the data were organized and cleaned 
solely for the study purposes. It would be interesting to consider or redefine inclusion 
criteria for a case status positive for anxiety. One might consider that case status for 
anxiety would be identified with two diagnostic codes in the record. It is possible that 
specificity could improve with this change. It would also be interesting to count the 
number of anxiety diagnoses one has on their medical record.   
Next, this project could be expanded to include other facets of functioning and 
increased sample size. The project could expand to include other psychiatric conditions in 
addition to anxiety. Investigators also have data on parent report of co-occurring 
psychiatric conditions, which other studies have found to correlate with the Mini PAS-
ADD, with the exception of co-occurring anxiety. It would be interesting to evaluate the 
association and correlation of diagnostic codes to parent report of co-occurring 
psychiatric conditions. These comparisons would also benefit from an increase in sample 
size.  
The Mini PAS-ADD was used in this study, as it is accepted as a reliable measure 




however, it has several limitations. Future research should include measures of better 
sensitivity and specificity. Additional measures of psychiatric conditions should also be 
included in the comparison to diagnostic codes.   
Lastly, adults with ASD and severely limited intellectual functioning and adaptive 
behavior were more likely to experience anxiety. These analyses primarily used Mini 
PAS-ADD case status; however, repeating these analyses with anxiety case status defined 
by diagnostic codes instead could reflect the amount to which providers in the 
community are identifying anxiety in individuals with ASD and severely limited 
intellectual functioning and adaptive behavior. This could also shed light on potential 
reasons diagnostic code data did not identify participants who actually have anxiety.   
 
Practical Implications  
 Results from this dissertation provided implications for the autism research 
community and community providers serving adults with ASD. Adults with ASD receive 
services from a variety of clinicians (e.g., school psychologists, clinical psychologists, 
psychiatrists, social workers, speech and language pathologists, and special education 
teachers). Many of these providers informally acknowledge that individuals with ASD 
experience and demonstrate many anxiety symptoms, but the high overlap of symptoms 
between ASD and anxiety and frequent lack of communication abilities make it difficult 
for clinicians to consistently identify anxiety in this population. This study provides 
information about the difficulty providers have in identifying co-occurring anxiety. The 
results provide an estimate of how many individuals with ASD might be experiencing co-




females. The results suggested that a large number of individuals who have limited 
intellectual and communication abilities also experience anxiety. In addition, the 
association between co-occurring anxiety and employment suggests that adults with ASD 
who have anxiety are more likely to be unemployed or require supported employment 
positions. This finding may suggest the need to consider co-occurring anxiety as a 
common obstacle faced by adults with ASD who struggle to maintain independent 
employment, potentially among those adults who otherwise have normal intellectual 
functioning.   
This dissertation provides insight into the difficulty researchers and clinicians 
have in identifying co-occurring anxiety in adults with ASD. The measurement 
challenges in this study and those reflected in the research demonstrate how difficult it 
can be for a clinician to determine whether an individual has anxiety. Unclear diagnoses 
or symptoms make it difficult to recommend appropriate interventions. This puts forth 
the importance that both the research and clinical fields may want to invest efforts into 
creating validated measures of anxiety in this population that could be implemented 
successfully in both research and clinical settings. Kerns, Renno, Kendall, Wood, and 
Storch (2016) have been pursuing projects that adapt an already validated assessment of 
anxiety, the Anxiety Disorders Interview Schedule, for individuals with ASD. 
Ozsivadjian, Hibberd, and Hollocks (2014) have done similar work to validate the use of 
current screeners and assessment measures in this population. Determining who has co-
occurring anxiety is vital for treatment planning and understanding the potential function 
of behaviors.  




study provide clinicians with further information of the proportion of their clients who 
may have co-occurring anxiety. While the estimates provided by this study are just that, 
estimates, this information suggests that clinicians may want to consider that a large 
proportion of their client base may be experiencing co-occurring anxiety. In addition, this 
study suggested that females with ASD may be experiencing higher rates of co-occurring 
anxiety than their male counterparts.  
One aim of this dissertation was to investigate the association of co-occurring 
anxiety and intellectual or adaptive behavior abilities. Results suggested that a large 
proportion of participants with anxiety also had severely limited intellectual functioning 
or adaptive behavior. These individuals typically have difficulty expressing their 
experiences, particularly in regards to complex topics such as emotional experiences. 
Given the high rate of anxiety in this population of adults with ASD, it is important for 
clinicians to consider how a client’s behavior or symptom presentation may relate to co-
occurring anxiety rather than other forms of emotional distress. For example, if an 
individual is displaying disruptive behaviors, such as agitation or aggression, it is 
important for the clinician to consider that these behaviors could be driven by anxiety 
rather than conceptualizing the disruptive behavior as a direct target for pharmaceutical 
or behavioral intervention. If the individual receives intervention for anxiety, behaviors 
precipitated by the individual’s experience of anxiety can recede with the use of 
interventions specific to anxiety and less problematic in regards to long-term health and 
tolerability. Identifying co-occurring anxiety in these individuals is important as is a 
focus on how to treat co-occurring anxiety in this population, particularly for those with 




interventions for individuals with ASD and co-occurring anxiety consist of therapy 
requiring high levels of communication skills (Wood et al., 2015).  
Lastly, when the presence of co-occurring anxiety was compared to employment 
status, participants with anxiety were more likely to be unemployed or in supported 
employment than participants without co-occurring anxiety. Alternatively, participants 
without anxiety were more likely to be independently employed. The sample sizes for 
this comparison were relatively small, so further investigation of this concept is needed. 
However, given the literature suggesting that co-occurring anxiety in the general 
population impacts one’s ability to work, it is not surprising that this phenomenon 
extends to those with ASD. When providers are aiding clients with ASD in their efforts to 
become employed, it could be beneficial to consider the impact co-occurring anxiety 
could have on these outcomes and subsequently implemented strategies to address 
anxiety when present.  
Overall, the clinical implications of this dissertation help to confirm clinical 
hypotheses that individuals with ASD experience higher than expected rates of anxiety. 
This insight could guide treatment planning. Furthermore, participants experiencing co-
occurring anxiety also experienced severely impaired intellectual and adaptive behavior 
functioning. These participants also tended to be female. Finally, an interaction was 
found between the presence of anxiety and employment. All of these factors provide 








The overall aim of this dissertation was to improve our understanding of co-
occurring anxiety in adults with ASD, both through measuring the prevalence of the 
disorder within a large cohort using complementary methods and evaluating consistency 
among results between these methods.  Specifically, this study aimed to evaluate the use 
of diagnostic codes to present the prevalence of co-occurring anxiety. Then, the aim was 
to present the prevalence of co-occurring anxiety in adults with ASD using a substantially 
larger sample than used previously, as well as to compare these prevalence rates to a 
control cohort. Diagnostic code data were found to have significant limitations when 
evaluating anxiety prevalence, which reflects several larger measurement issues and 
clinical implications. The prevalence of anxiety was presented and found to affect almost 
half of the participants with ASD, a much larger proportion than the control cohort. 
Lastly, co-occurring anxiety was associated with employment status, potentially 
suggesting an avenue for further research or focus of intervention.   
In this study, diagnostic codes were found to have several limitations when 
compared to an in-person assessment of co-occurring psychiatric conditions. Diagnostic 
codes were found to have both low sensitivity and specificity, indicating that this 
measurement tool is limited in its ability to accurately identify anxiety among adults with 
ASD. This finding was important but also limited because diagnostic codes were 
compared to the Mini PAS-ADD, which had its own reliability and validity limitations 
such as low sensitivity and specificity (Janssen & Maes, 2013). Visual analysis showed 
that both measures appeared to be measuring anxiety somewhat similarly, but more in-




Neither measurement tool was really effective in measuring co-occurring anxiety in this 
population. It speaks to the need for further measurement development.   
Anxiety was found to affect over half of the population of adults with ASD in this 
study. This has immense implications for providers and researchers in the field. Few 
published studies have presented findings in a sample of this size. This study was able to 
reflect on a large number of adults with ASD who also experience anxiety. In addition, a 
large proportion of the participants in this study had significantly limited cognitive and/or 
communication abilities. A large proportion of participants with these limited abilities 
were found to have anxiety, indicating the further need to screen for, monitor, and 
investigate anxiety in adults with autism. Lastly, anxiety was found to be associated with 
factors of employment. Previous research has implied that adults with anxiety could have 
worsened outcomes of education or employment. This phenomenon is seen in adults with 
ASD, as many studies suggest that these individuals have poor outcomes. The current 
study reflects a potential additional factor implicating adult outcomes, which should be 
researched further.   
In conclusion, this study had several limitations but also provided a wealth of 
information for the field of psychology and ASD research. In particular, this study helps 
provide a comparison study to the only other large-scale study using diagnostic codes to 
measure co-occurring psychiatric conditions. The current study provides a reference point 
for which one could compare this previous study. The limitations of this study reflected 
larger measurement and sample restrictions. The measurement issues have implications 





are frequently impacted by a co-occurring anxiety. This should be considered in future 
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